ES2248302T3 - Utilizacion de cianoquinolinas para el tratamiento o la inhibicion de polipos colonicos. - Google Patents
Utilizacion de cianoquinolinas para el tratamiento o la inhibicion de polipos colonicos.Info
- Publication number
- ES2248302T3 ES2248302T3 ES01918367T ES01918367T ES2248302T3 ES 2248302 T3 ES2248302 T3 ES 2248302T3 ES 01918367 T ES01918367 T ES 01918367T ES 01918367 T ES01918367 T ES 01918367T ES 2248302 T3 ES2248302 T3 ES 2248302T3
- Authority
- ES
- Spain
- Prior art keywords
- amino
- carbonitrile
- phenylamino
- quinolinecarbonitrile
- cyano
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000011282 treatment Methods 0.000 title claims description 34
- 230000005764 inhibitory process Effects 0.000 title claims description 7
- 230000000112 colonic effect Effects 0.000 title claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 205
- -1 nitro, carboxy Chemical group 0.000 claims abstract description 167
- 150000001875 compounds Chemical class 0.000 claims abstract description 98
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 89
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 45
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 20
- 125000001424 substituent group Chemical group 0.000 claims abstract description 18
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 13
- 125000003282 alkyl amino group Chemical group 0.000 claims abstract description 12
- 125000004663 dialkyl amino group Chemical group 0.000 claims abstract description 12
- 125000004970 halomethyl group Chemical group 0.000 claims abstract description 12
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 11
- 125000004849 alkoxymethyl group Chemical group 0.000 claims abstract description 11
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 11
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 11
- 125000000304 alkynyl group Chemical group 0.000 claims abstract description 10
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 10
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 9
- 125000005042 acyloxymethyl group Chemical group 0.000 claims abstract description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 6
- 125000005843 halogen group Chemical group 0.000 claims abstract description 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims abstract description 6
- 125000004076 pyridyl group Chemical group 0.000 claims abstract description 6
- 125000000714 pyrimidinyl group Chemical group 0.000 claims abstract description 6
- 125000005236 alkanoylamino group Chemical group 0.000 claims abstract description 4
- 125000006323 alkenyl amino group Chemical group 0.000 claims abstract description 4
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims abstract description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims abstract description 4
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims abstract description 3
- 239000002253 acid Substances 0.000 claims description 138
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 57
- 229910052799 carbon Inorganic materials 0.000 claims description 42
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims description 39
- ZRTXZWXHWPAXFT-UHFFFAOYSA-N 6-amino-4-(3-bromoanilino)quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 ZRTXZWXHWPAXFT-UHFFFAOYSA-N 0.000 claims description 38
- 125000004429 atom Chemical group 0.000 claims description 32
- 229910052757 nitrogen Inorganic materials 0.000 claims description 18
- 239000001257 hydrogen Substances 0.000 claims description 17
- 229910052739 hydrogen Inorganic materials 0.000 claims description 17
- IMBMTYREOJZAAW-UHFFFAOYSA-N 6-amino-4-(3-bromoanilino)-7-methoxyquinoline-3-carbonitrile Chemical compound C=12C=C(N)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 IMBMTYREOJZAAW-UHFFFAOYSA-N 0.000 claims description 16
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 12
- WMSREFWREGHLAP-UHFFFAOYSA-N 6-amino-4-(3-chloro-4-fluoroanilino)quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(Cl)=C1 WMSREFWREGHLAP-UHFFFAOYSA-N 0.000 claims description 11
- GFPFGXYUPCOMGW-UHFFFAOYSA-N 6-amino-4-(3-bromoanilino)-8-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC(N)=CC2=C1NC1=CC=CC(Br)=C1 GFPFGXYUPCOMGW-UHFFFAOYSA-N 0.000 claims description 10
- MJOPKUFLFODTKP-UHFFFAOYSA-N 6-amino-4-(3-chloro-4-fluoroanilino)-7-methoxyquinoline-3-carbonitrile Chemical compound C=12C=C(N)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C(Cl)=C1 MJOPKUFLFODTKP-UHFFFAOYSA-N 0.000 claims description 10
- DXWBLHXTKOUIHA-UHFFFAOYSA-N 6-amino-4-(3-bromoanilino)-7-ethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(N)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 DXWBLHXTKOUIHA-UHFFFAOYSA-N 0.000 claims description 9
- 150000002367 halogens Chemical class 0.000 claims description 9
- WMIBAZLHGIVWSU-UHFFFAOYSA-N 6-amino-4-(3-bromo-4-fluoroanilino)-7-methoxyquinoline-3-carbonitrile Chemical compound C=12C=C(N)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C(Br)=C1 WMIBAZLHGIVWSU-UHFFFAOYSA-N 0.000 claims description 8
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 8
- 125000005422 alkyl sulfonamido group Chemical group 0.000 claims description 8
- AIQFOGOHLOICRK-UHFFFAOYSA-N 6-amino-4-(3-chloro-4-fluoroanilino)-7-ethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(N)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C(Cl)=C1 AIQFOGOHLOICRK-UHFFFAOYSA-N 0.000 claims description 7
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 7
- UMAUXDSUHUAKMF-UHFFFAOYSA-N chembl111586 Chemical compound C=12C=C(O)C(O)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 UMAUXDSUHUAKMF-UHFFFAOYSA-N 0.000 claims description 7
- 239000000460 chlorine Substances 0.000 claims description 7
- CLGJOTLYNXUVES-UHFFFAOYSA-N 6-amino-4-(3-bromo-4-fluoroanilino)quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(Br)=C1 CLGJOTLYNXUVES-UHFFFAOYSA-N 0.000 claims description 6
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 6
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 6
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 6
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 6
- GEUFKSXFZJFSDI-UHFFFAOYSA-N 4-[3-(hydroxymethyl)anilino]-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(CO)=C1 GEUFKSXFZJFSDI-UHFFFAOYSA-N 0.000 claims description 5
- AJSYUAVIQGKJFW-UHFFFAOYSA-N 6-amino-4-(3,4-dibromoanilino)quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=C(Br)C(Br)=C1 AJSYUAVIQGKJFW-UHFFFAOYSA-N 0.000 claims description 5
- PFVDWAYDYKHDEH-UHFFFAOYSA-N 6-amino-4-(3-bromoanilino)-8-[(dimethylamino)methyl]quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(CN(C)C)=CC(N)=CC2=C1NC1=CC=CC(Br)=C1 PFVDWAYDYKHDEH-UHFFFAOYSA-N 0.000 claims description 5
- MJPIXAAXFZASFT-UHFFFAOYSA-N 6-amino-4-(3-ethynylanilino)quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=CC(C#C)=C1 MJPIXAAXFZASFT-UHFFFAOYSA-N 0.000 claims description 5
- OXXUZYBVAKGKQB-UHFFFAOYSA-N 6-amino-4-(3-methoxyanilino)quinoline-3-carbonitrile Chemical compound COC1=CC=CC(NC=2C3=CC(N)=CC=C3N=CC=2C#N)=C1 OXXUZYBVAKGKQB-UHFFFAOYSA-N 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- 125000004423 acyloxy group Chemical group 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- IYVDPTGYWDFGTF-VOTSOKGWSA-N (e)-n-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]-3-chloroprop-2-enamide Chemical compound C12=CC(NC(=O)/C=C/Cl)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 IYVDPTGYWDFGTF-VOTSOKGWSA-N 0.000 claims description 4
- IYVDPTGYWDFGTF-SREVYHEPSA-N (z)-n-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]-3-chloroprop-2-enamide Chemical compound C12=CC(NC(=O)\C=C/Cl)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 IYVDPTGYWDFGTF-SREVYHEPSA-N 0.000 claims description 4
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 4
- RUGCZQOSGFAGFE-UHFFFAOYSA-N 4-(3,4-dibromoanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=C(Br)C(Br)=C1 RUGCZQOSGFAGFE-UHFFFAOYSA-N 0.000 claims description 4
- MZQKSJFIOAVZJR-UHFFFAOYSA-N 4-(3-aminoanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(N)=C1 MZQKSJFIOAVZJR-UHFFFAOYSA-N 0.000 claims description 4
- BISJVYCVPJVRKJ-UHFFFAOYSA-N 4-(3-bromoanilino)-7-methoxy-6-nitroquinoline-3-carbonitrile Chemical compound C=12C=C([N+]([O-])=O)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 BISJVYCVPJVRKJ-UHFFFAOYSA-N 0.000 claims description 4
- VCNRVJKPJCKMIG-UHFFFAOYSA-N 4-(3-chloro-4-fluoroanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(Cl)=C1 VCNRVJKPJCKMIG-UHFFFAOYSA-N 0.000 claims description 4
- XFOAIBYWZWBMSL-UHFFFAOYSA-N 4-(3-hydroxy-2-methylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(O)=C1C XFOAIBYWZWBMSL-UHFFFAOYSA-N 0.000 claims description 4
- ZRBPCTDCKOQMBZ-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCCl)C(OC)=CC2=C1NC1=CC=C(Cl)C=C1F ZRBPCTDCKOQMBZ-UHFFFAOYSA-N 0.000 claims description 4
- PDQUVNBKITWFNZ-UHFFFAOYSA-N 6-amino-4-(3-cyanoanilino)quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=CC(C#N)=C1 PDQUVNBKITWFNZ-UHFFFAOYSA-N 0.000 claims description 4
- JSRLAMXXELZKLJ-UHFFFAOYSA-N 6-amino-4-[3-(trifluoromethyl)anilino]quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=CC(C(F)(F)F)=C1 JSRLAMXXELZKLJ-UHFFFAOYSA-N 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- 150000001408 amides Chemical class 0.000 claims description 4
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- RRPOWKSQIHLYPG-UHFFFAOYSA-N n-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]-2-methylprop-2-enamide Chemical compound C12=CC(NC(=O)C(=C)C)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 RRPOWKSQIHLYPG-UHFFFAOYSA-N 0.000 claims description 4
- GCNKUJAIEDINLA-UHFFFAOYSA-N 4-(2-hydroxy-6-methylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=C(C)C=CC=C1O GCNKUJAIEDINLA-UHFFFAOYSA-N 0.000 claims description 3
- WYUJPMJLGOVLKG-UHFFFAOYSA-N 4-(3,4-difluoroanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(F)=C1 WYUJPMJLGOVLKG-UHFFFAOYSA-N 0.000 claims description 3
- PPNMPEHEXLGGID-UHFFFAOYSA-N 4-(3,4-dimethoxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C1=C(OC)C(OC)=CC=C1NC1=C(C#N)C=NC2=CC(OC)=C(OC)C=C12 PPNMPEHEXLGGID-UHFFFAOYSA-N 0.000 claims description 3
- JCGYXRCAGZQKRK-UHFFFAOYSA-N 4-(3-bromo-4-fluoroanilino)-7-methoxy-6-nitroquinoline-3-carbonitrile Chemical compound C=12C=C([N+]([O-])=O)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C(Br)=C1 JCGYXRCAGZQKRK-UHFFFAOYSA-N 0.000 claims description 3
- BOXDQGATHFGEIB-UHFFFAOYSA-N 4-(3-bromo-4-methylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(C)C(Br)=C1 BOXDQGATHFGEIB-UHFFFAOYSA-N 0.000 claims description 3
- UHTFOMCCUZQBMM-UHFFFAOYSA-N 4-(3-bromoanilino)-5,8-dimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=C(OC)C2=C1NC1=CC=CC(Br)=C1 UHTFOMCCUZQBMM-UHFFFAOYSA-N 0.000 claims description 3
- TUZMSVARIRHFNQ-UHFFFAOYSA-N 4-(3-bromoanilino)-6,7-bis(methoxymethoxy)quinoline-3-carbonitrile Chemical compound C=12C=C(OCOC)C(OCOC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 TUZMSVARIRHFNQ-UHFFFAOYSA-N 0.000 claims description 3
- ZXILYRWRAKLTOG-UHFFFAOYSA-N 4-(3-bromoanilino)-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 ZXILYRWRAKLTOG-UHFFFAOYSA-N 0.000 claims description 3
- CQKFTSMPIIYOBX-UHFFFAOYSA-N 4-(3-bromoanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 CQKFTSMPIIYOBX-UHFFFAOYSA-N 0.000 claims description 3
- IKOYWGLBVGPRAG-UHFFFAOYSA-N 4-(3-bromoanilino)-6-ethoxy-7-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OC)C(OCC)=CC2=C1NC1=CC=CC(Br)=C1 IKOYWGLBVGPRAG-UHFFFAOYSA-N 0.000 claims description 3
- SNLXBZYKYWEIOV-UHFFFAOYSA-N 4-(3-bromoanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 SNLXBZYKYWEIOV-UHFFFAOYSA-N 0.000 claims description 3
- JGTPCHRGCCPWCC-UHFFFAOYSA-N 4-(3-bromoanilino)-7-ethoxy-6-nitroquinoline-3-carbonitrile Chemical compound C=12C=C([N+]([O-])=O)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 JGTPCHRGCCPWCC-UHFFFAOYSA-N 0.000 claims description 3
- NUBVTRDETNNCGY-UHFFFAOYSA-N 4-(3-bromoanilino)-7-methoxyquinoline-3-carbonitrile Chemical compound N#CC=1C=NC2=CC(OC)=CC=C2C=1NC1=CC=CC(Br)=C1 NUBVTRDETNNCGY-UHFFFAOYSA-N 0.000 claims description 3
- OESIRSGDGHCWFH-UHFFFAOYSA-N 4-(3-bromoanilino)-8-[(dimethylamino)methyl]-6-nitroquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(CN(C)C)=CC([N+]([O-])=O)=CC2=C1NC1=CC=CC(Br)=C1 OESIRSGDGHCWFH-UHFFFAOYSA-N 0.000 claims description 3
- UOGAQYCATMQBLI-UHFFFAOYSA-N 4-(3-bromoanilino)-8-methoxy-6-nitroquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC([N+]([O-])=O)=CC2=C1NC1=CC=CC(Br)=C1 UOGAQYCATMQBLI-UHFFFAOYSA-N 0.000 claims description 3
- AFOMMVJBDXYOAA-UHFFFAOYSA-N 4-(3-bromoanilino)-8-methyl-6-nitroquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(C)=CC([N+]([O-])=O)=CC2=C1NC1=CC=CC(Br)=C1 AFOMMVJBDXYOAA-UHFFFAOYSA-N 0.000 claims description 3
- JPDTVCOEUUQNSS-UHFFFAOYSA-N 4-(3-bromophenoxy)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1OC1=CC=CC(Br)=C1 JPDTVCOEUUQNSS-UHFFFAOYSA-N 0.000 claims description 3
- GLDODVVYHDNXHG-UHFFFAOYSA-N 4-(3-chloro-2-thiophen-3-yloxyanilino)-6-nitroquinoline-3-carbonitrile Chemical compound ClC=1C(=C(C=CC=1)NC1=C(C=NC2=CC=C(C=C12)[N+](=O)[O-])C#N)OC=1C=CSC=1 GLDODVVYHDNXHG-UHFFFAOYSA-N 0.000 claims description 3
- IJAFEDNMGMKIIZ-UHFFFAOYSA-N 4-(3-chloro-4-fluoroanilino)-7-methoxy-6-nitroquinoline-3-carbonitrile Chemical compound C=12C=C([N+]([O-])=O)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C(Cl)=C1 IJAFEDNMGMKIIZ-UHFFFAOYSA-N 0.000 claims description 3
- DUDXBCAIXIMAKI-UHFFFAOYSA-N 4-(3-chloro-4-hydroxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(O)C(Cl)=C1 DUDXBCAIXIMAKI-UHFFFAOYSA-N 0.000 claims description 3
- HLBGGOYPNRIHFH-UHFFFAOYSA-N 4-(3-chloroanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Cl)=C1 HLBGGOYPNRIHFH-UHFFFAOYSA-N 0.000 claims description 3
- FNRKKHMPSZQHEJ-UHFFFAOYSA-N 4-(3-chloroanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=CC(Cl)=C1 FNRKKHMPSZQHEJ-UHFFFAOYSA-N 0.000 claims description 3
- CCECSDRSBLPTHW-UHFFFAOYSA-N 4-(3-cyanoanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(C#N)=C1 CCECSDRSBLPTHW-UHFFFAOYSA-N 0.000 claims description 3
- QEPNPWOGJRAAOQ-UHFFFAOYSA-N 4-(3-cyanoanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=CC(C#N)=C1 QEPNPWOGJRAAOQ-UHFFFAOYSA-N 0.000 claims description 3
- PLWCWVLZUBYBEW-UHFFFAOYSA-N 4-(3-ethynylanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=CC(C#C)=C1 PLWCWVLZUBYBEW-UHFFFAOYSA-N 0.000 claims description 3
- ADYHMPMHENUUSX-UHFFFAOYSA-N 4-(3-hydroxy-4-methylanilino)-5,8-dimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=C(OC)C2=C1NC1=CC=C(C)C(O)=C1 ADYHMPMHENUUSX-UHFFFAOYSA-N 0.000 claims description 3
- HDYIFTHEJLLDHZ-UHFFFAOYSA-N 4-(3-hydroxy-4-methylanilino)-6,7,8-trimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=C(OC)C(OC)=CC2=C1NC1=CC=C(C)C(O)=C1 HDYIFTHEJLLDHZ-UHFFFAOYSA-N 0.000 claims description 3
- RMENKSJNOQJIGF-UHFFFAOYSA-N 4-(3-hydroxy-4-methylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(C)C(O)=C1 RMENKSJNOQJIGF-UHFFFAOYSA-N 0.000 claims description 3
- DLQVSGGYBADFFQ-UHFFFAOYSA-N 4-(3-iodoanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=CC(I)=C1 DLQVSGGYBADFFQ-UHFFFAOYSA-N 0.000 claims description 3
- CFEACTBBVRNDBB-UHFFFAOYSA-N 4-(3-methoxyanilino)-6-nitroquinoline-3-carbonitrile Chemical compound COC1=CC=CC(NC=2C3=CC(=CC=C3N=CC=2C#N)[N+]([O-])=O)=C1 CFEACTBBVRNDBB-UHFFFAOYSA-N 0.000 claims description 3
- FMAZODAHMSMUNK-UHFFFAOYSA-N 4-(3-methylanilino)-6-nitroquinoline-3-carbonitrile Chemical compound CC1=CC=CC(NC=2C3=CC(=CC=C3N=CC=2C#N)[N+]([O-])=O)=C1 FMAZODAHMSMUNK-UHFFFAOYSA-N 0.000 claims description 3
- KBQXQEITHBAZNL-UHFFFAOYSA-N 4-(4-chloro-2-fluoro-5-hydroxyanilino)-5,8-dimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=C(OC)C2=C1NC1=CC(O)=C(Cl)C=C1F KBQXQEITHBAZNL-UHFFFAOYSA-N 0.000 claims description 3
- NXQUVEFCIXDBGX-UHFFFAOYSA-N 4-(4-chloro-2-fluoro-5-hydroxyanilino)-6,7,8-trimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=C(OC)C(OC)=CC2=C1NC1=CC(O)=C(Cl)C=C1F NXQUVEFCIXDBGX-UHFFFAOYSA-N 0.000 claims description 3
- HXFOGGVVVXAAAY-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-5,8-dimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=C(OC)C2=C1NC1=CC=C(Cl)C=C1F HXFOGGVVVXAAAY-UHFFFAOYSA-N 0.000 claims description 3
- AZGVCABJHURYHG-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(Cl)C=C1F AZGVCABJHURYHG-UHFFFAOYSA-N 0.000 claims description 3
- PICBGXSASXFIAL-UHFFFAOYSA-N 4-(4-fluoroanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C=C1 PICBGXSASXFIAL-UHFFFAOYSA-N 0.000 claims description 3
- REBRBTLJKXGAAU-UHFFFAOYSA-N 4-(cyclohexylamino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1CCCCC1 REBRBTLJKXGAAU-UHFFFAOYSA-N 0.000 claims description 3
- XHHYAWSDIXRRAO-UHFFFAOYSA-N 4-[3-(chloromethyl)anilino]-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(CCl)=C1 XHHYAWSDIXRRAO-UHFFFAOYSA-N 0.000 claims description 3
- OVFOWMBZHBTKLD-UHFFFAOYSA-N 4-[3-(dimethylamino)anilino]-5,8-dimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=C(OC)C2=C1NC1=CC=CC(N(C)C)=C1 OVFOWMBZHBTKLD-UHFFFAOYSA-N 0.000 claims description 3
- LMPUEJSCCKBFOV-UHFFFAOYSA-N 4-[3-(dimethylamino)anilino]-6,7,8-trimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=C(OC)C(OC)=CC2=C1NC1=CC=CC(N(C)C)=C1 LMPUEJSCCKBFOV-UHFFFAOYSA-N 0.000 claims description 3
- YXCSSHCCXLUHDG-UHFFFAOYSA-N 6,7-dimethoxy-4-(2-methylanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC=C1C YXCSSHCCXLUHDG-UHFFFAOYSA-N 0.000 claims description 3
- QBPFCLKAEGQCJR-UHFFFAOYSA-N 6,7-dimethoxy-4-(2-methylsulfanylanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC=C1SC QBPFCLKAEGQCJR-UHFFFAOYSA-N 0.000 claims description 3
- WEOXCMIQDJTOOP-UHFFFAOYSA-N 6,7-dimethoxy-4-(3-nitroanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC([N+]([O-])=O)=C1 WEOXCMIQDJTOOP-UHFFFAOYSA-N 0.000 claims description 3
- NPVUUFCFLLPVCM-UHFFFAOYSA-N 6,7-dimethoxy-4-[3-(trifluoromethyl)anilino]quinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(C(F)(F)F)=C1 NPVUUFCFLLPVCM-UHFFFAOYSA-N 0.000 claims description 3
- LEACUGBTKYYIDG-UHFFFAOYSA-N 6-amino-4-(3,4-difluoroanilino)quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(F)=C1 LEACUGBTKYYIDG-UHFFFAOYSA-N 0.000 claims description 3
- DRHNHDZBMACOEW-UHFFFAOYSA-N 6-amino-4-(3-chloro-2-thiophen-3-yloxyanilino)quinoline-3-carbonitrile Chemical compound NC=1C=C2C(=C(C=NC2=CC=1)C#N)NC1=C(C(=CC=C1)Cl)OC=1C=CSC=1 DRHNHDZBMACOEW-UHFFFAOYSA-N 0.000 claims description 3
- IUHXMKMPNZOIIR-UHFFFAOYSA-N 6-amino-4-(3-chloroanilino)quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Cl)=C1 IUHXMKMPNZOIIR-UHFFFAOYSA-N 0.000 claims description 3
- JSCNIEOKVSQSKM-UHFFFAOYSA-N 6-amino-4-(3-iodoanilino)quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=CC(I)=C1 JSCNIEOKVSQSKM-UHFFFAOYSA-N 0.000 claims description 3
- PNHLUCIDSVSCDW-UHFFFAOYSA-N 6-amino-4-(3-methylanilino)quinoline-3-carbonitrile Chemical compound CC1=CC=CC(NC=2C3=CC(N)=CC=C3N=CC=2C#N)=C1 PNHLUCIDSVSCDW-UHFFFAOYSA-N 0.000 claims description 3
- SIBQYOKZVKAXSA-UHFFFAOYSA-N 6-amino-4-(4-bromoanilino)quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=C(Br)C=C1 SIBQYOKZVKAXSA-UHFFFAOYSA-N 0.000 claims description 3
- YOOVBYGMAALDAY-UHFFFAOYSA-N 6-ethoxy-4-(3-hydroxy-4-methylanilino)-7-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OC)C(OCC)=CC2=C1NC1=CC=C(C)C(O)=C1 YOOVBYGMAALDAY-UHFFFAOYSA-N 0.000 claims description 3
- WUVXAOGFNCAWFT-UHFFFAOYSA-N 6-nitro-4-[3-(trifluoromethyl)anilino]quinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=CC(C(F)(F)F)=C1 WUVXAOGFNCAWFT-UHFFFAOYSA-N 0.000 claims description 3
- AVKRWJGYHFZIQI-UHFFFAOYSA-N 8-(3-bromoanilino)-[1,3]dioxolo[4,5-g]quinoline-7-carbonitrile Chemical compound BrC1=CC=CC(NC=2C3=CC=4OCOC=4C=C3N=CC=2C#N)=C1 AVKRWJGYHFZIQI-UHFFFAOYSA-N 0.000 claims description 3
- 241000124008 Mammalia Species 0.000 claims description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 3
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims description 3
- XNWKTBYXWIDLCZ-UHFFFAOYSA-N n-[3-cyano-4-(3-fluoroanilino)quinolin-6-yl]prop-2-enamide Chemical compound FC1=CC=CC(NC=2C3=CC(NC(=O)C=C)=CC=C3N=CC=2C#N)=C1 XNWKTBYXWIDLCZ-UHFFFAOYSA-N 0.000 claims description 3
- KXQYGHZAGFHMDJ-ARJAWSKDSA-N (z)-n-[4-(3-chloro-4-fluoroanilino)-3-cyanoquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound C12=CC(NC(=O)\C=C/CN(C)C)=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(Cl)=C1 KXQYGHZAGFHMDJ-ARJAWSKDSA-N 0.000 claims description 2
- RIQABCQFNMRXGD-IHWYPQMZSA-N (z)-n-[4-(3-chloro-4-fluoroanilino)-3-cyanoquinolin-6-yl]-4-methoxybut-2-enamide Chemical compound C12=CC(NC(=O)\C=C/COC)=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(Cl)=C1 RIQABCQFNMRXGD-IHWYPQMZSA-N 0.000 claims description 2
- XBFPRUXDYAQIOC-UHFFFAOYSA-N 4-(3-acetylanilino)-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=CC(C(C)=O)=C1 XBFPRUXDYAQIOC-UHFFFAOYSA-N 0.000 claims description 2
- WLEQBEYGUJEPBI-UHFFFAOYSA-N 4-(3-bromo-4-fluoroanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(Br)=C1 WLEQBEYGUJEPBI-UHFFFAOYSA-N 0.000 claims description 2
- VXMFIYMOOZZNJO-UHFFFAOYSA-N 4-(3-bromoanilino)-6,7,8-trimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=C(OC)C(OC)=CC2=C1NC1=CC=CC(Br)=C1 VXMFIYMOOZZNJO-UHFFFAOYSA-N 0.000 claims description 2
- WCNVEOXERDZIOX-UHFFFAOYSA-N 4-(3-bromoanilino)-7-ethoxy-6-methoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 WCNVEOXERDZIOX-UHFFFAOYSA-N 0.000 claims description 2
- VJTVBWNBERHDKM-UHFFFAOYSA-N 4-(3-chloro-4-fluoroanilino)-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C(Cl)=C1 VJTVBWNBERHDKM-UHFFFAOYSA-N 0.000 claims description 2
- PSZDFZSOCJHJRP-UHFFFAOYSA-N 4-(3-chloro-4-phenylsulfanylanilino)-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NC(C=C1Cl)=CC=C1SC1=CC=CC=C1 PSZDFZSOCJHJRP-UHFFFAOYSA-N 0.000 claims description 2
- FDTYUDRPBMYHKE-UHFFFAOYSA-N 4-(3-chloro-4-phenylsulfanylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC(C=C1Cl)=CC=C1SC1=CC=CC=C1 FDTYUDRPBMYHKE-UHFFFAOYSA-N 0.000 claims description 2
- XEYIOOPOGZOAEP-UHFFFAOYSA-N 4-(3-chloroanilino)-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Cl)=C1 XEYIOOPOGZOAEP-UHFFFAOYSA-N 0.000 claims description 2
- OLNMDVMEJYNZBA-UHFFFAOYSA-N 4-(3-fluoroanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(F)=C1 OLNMDVMEJYNZBA-UHFFFAOYSA-N 0.000 claims description 2
- DPAMNPPLTWUUOW-UHFFFAOYSA-N 4-(3-hydroxy-4-methylanilino)-6-methoxy-7-(2-morpholin-4-ylethoxy)quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCN3CCOCC3)C(OC)=CC2=C1NC1=CC=C(C)C(O)=C1 DPAMNPPLTWUUOW-UHFFFAOYSA-N 0.000 claims description 2
- DNGLYZBHHHXJDG-UHFFFAOYSA-N 4-(4-bromophenyl)sulfanyl-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1SC1=CC=C(Br)C=C1 DNGLYZBHHHXJDG-UHFFFAOYSA-N 0.000 claims description 2
- AHEZGLOWOWBLAP-UHFFFAOYSA-N 4-(4-chloro-2-fluoro-5-hydroxyanilino)-6-methoxy-7-(2-morpholin-4-ylethoxy)quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCN3CCOCC3)C(OC)=CC2=C1NC1=CC(O)=C(Cl)C=C1F AHEZGLOWOWBLAP-UHFFFAOYSA-N 0.000 claims description 2
- RDVLPEPWSGCECJ-UHFFFAOYSA-N 4-(4-chloro-2-fluoro-5-hydroxyanilino)-6-methoxy-7-(3-morpholin-4-ylpropoxy)quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1NC1=CC(O)=C(Cl)C=C1F RDVLPEPWSGCECJ-UHFFFAOYSA-N 0.000 claims description 2
- ISCIEBIOIJWXOX-UHFFFAOYSA-N 4-(4-chloro-2-fluoro-5-hydroxyanilino)-7-[2-(dimethylamino)ethoxy]-6-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCN(C)C)C(OC)=CC2=C1NC1=CC(O)=C(Cl)C=C1F ISCIEBIOIJWXOX-UHFFFAOYSA-N 0.000 claims description 2
- WUTUYQSMZJUIDT-UHFFFAOYSA-N 4-(4-chloro-2-fluoro-5-hydroxyanilino)-7-[3-(dimethylamino)propoxy]-6-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCN(C)C)C(OC)=CC2=C1NC1=CC(O)=C(Cl)C=C1F WUTUYQSMZJUIDT-UHFFFAOYSA-N 0.000 claims description 2
- DCCQITVOSPOELC-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-6,7,8-trimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=C(OC)C(OC)=CC2=C1NC1=CC=C(Cl)C=C1F DCCQITVOSPOELC-UHFFFAOYSA-N 0.000 claims description 2
- UCTHWZMWNQJTQN-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-6-methoxy-7-(3-morpholin-4-ylpropoxy)quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1NC1=CC=C(Cl)C=C1F UCTHWZMWNQJTQN-UHFFFAOYSA-N 0.000 claims description 2
- KSTABQDMPVWBQA-UHFFFAOYSA-N 4-[(3,4-dichlorophenyl)methylamino]-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NCC1=CC=C(Cl)C(Cl)=C1 KSTABQDMPVWBQA-UHFFFAOYSA-N 0.000 claims description 2
- ZXRTVLOBTDWRJL-UHFFFAOYSA-N 4-[(3,4-dimethoxyphenyl)methylamino]-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NCC1=CC=C(OC)C(OC)=C1 ZXRTVLOBTDWRJL-UHFFFAOYSA-N 0.000 claims description 2
- MOMWLTJRHZNPRC-UHFFFAOYSA-N 4-[(3-bromophenyl)methylamino]-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NCC1=CC=CC(Br)=C1 MOMWLTJRHZNPRC-UHFFFAOYSA-N 0.000 claims description 2
- OFWSZEIPLOQZGP-UHFFFAOYSA-N 4-[[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]amino]-2-methylidene-4-oxobutanoic acid Chemical compound C12=CC(NC(=O)CC(=C)C(=O)O)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 OFWSZEIPLOQZGP-UHFFFAOYSA-N 0.000 claims description 2
- SHNLPCUCDONAQF-UHFFFAOYSA-N 4-anilino-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=CC=C1 SHNLPCUCDONAQF-UHFFFAOYSA-N 0.000 claims description 2
- YIUAOQMDEABCMH-UHFFFAOYSA-N 6,7-diethoxy-4-(3-fluoroanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=CC(F)=C1 YIUAOQMDEABCMH-UHFFFAOYSA-N 0.000 claims description 2
- BTUDPTQPRPWGQY-UHFFFAOYSA-N 6,7-diethoxy-4-(4-fluoro-2-methylanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C=C1C BTUDPTQPRPWGQY-UHFFFAOYSA-N 0.000 claims description 2
- KLJORPXEIAZGDJ-UHFFFAOYSA-N 6,7-diethoxy-4-(n-methylanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1N(C)C1=CC=CC=C1 KLJORPXEIAZGDJ-UHFFFAOYSA-N 0.000 claims description 2
- UPINFBFRHUFCMT-UHFFFAOYSA-N 6-amino-4-(3-fluoroanilino)quinoline-3-carbonitrile Chemical compound C12=CC(N)=CC=C2N=CC(C#N)=C1NC1=CC=CC(F)=C1 UPINFBFRHUFCMT-UHFFFAOYSA-N 0.000 claims description 2
- PVZCNRGQTKOEAH-UHFFFAOYSA-N 7-[2-(dimethylamino)ethoxy]-4-(3-hydroxy-4-methylanilino)-6-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCN(C)C)C(OC)=CC2=C1NC1=CC=C(C)C(O)=C1 PVZCNRGQTKOEAH-UHFFFAOYSA-N 0.000 claims description 2
- ZUZYWMSAFACAAG-UHFFFAOYSA-N 7-ethoxy-4-(3-hydroxy-4-methylanilino)-6-methoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=C(C)C(O)=C1 ZUZYWMSAFACAAG-UHFFFAOYSA-N 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 125000001153 fluoro group Chemical group F* 0.000 claims description 2
- ADTHOQASRLCLRF-UHFFFAOYSA-N n-[3-[(3-cyano-6,7-dimethoxyquinolin-4-yl)amino]phenyl]acetamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(NC(C)=O)=C1 ADTHOQASRLCLRF-UHFFFAOYSA-N 0.000 claims description 2
- LUNOJOWDCVLIRF-UHFFFAOYSA-N n-[3-cyano-4-(3,4-dibromoanilino)quinolin-6-yl]prop-2-enamide Chemical compound C1=C(Br)C(Br)=CC=C1NC1=C(C#N)C=NC2=CC=C(NC(=O)C=C)C=C12 LUNOJOWDCVLIRF-UHFFFAOYSA-N 0.000 claims description 2
- SQGPYBQAQIKBQS-UHFFFAOYSA-N n-[3-cyano-4-(3,4-difluoroanilino)quinolin-6-yl]prop-2-enamide Chemical compound C1=C(F)C(F)=CC=C1NC1=C(C#N)C=NC2=CC=C(NC(=O)C=C)C=C12 SQGPYBQAQIKBQS-UHFFFAOYSA-N 0.000 claims description 2
- VMWRFOQWNJQIMZ-UHFFFAOYSA-N n-[3-cyano-4-(3-cyanoanilino)quinolin-6-yl]prop-2-enamide Chemical compound C12=CC(NC(=O)C=C)=CC=C2N=CC(C#N)=C1NC1=CC=CC(C#N)=C1 VMWRFOQWNJQIMZ-UHFFFAOYSA-N 0.000 claims description 2
- WQTFCVASSZGLCT-UHFFFAOYSA-N n-[3-cyano-4-(3-ethynylanilino)quinolin-6-yl]prop-2-enamide Chemical compound C12=CC(NC(=O)C=C)=CC=C2N=CC(C#N)=C1NC1=CC=CC(C#C)=C1 WQTFCVASSZGLCT-UHFFFAOYSA-N 0.000 claims description 2
- RKKMOSSRGMBZAO-UHFFFAOYSA-N n-[3-cyano-4-(3-iodoanilino)quinolin-6-yl]prop-2-enamide Chemical compound IC1=CC=CC(NC=2C3=CC(NC(=O)C=C)=CC=C3N=CC=2C#N)=C1 RKKMOSSRGMBZAO-UHFFFAOYSA-N 0.000 claims description 2
- JEVROOVJYXQOEZ-UHFFFAOYSA-N n-[3-cyano-4-(3-methoxyanilino)quinolin-6-yl]prop-2-enamide Chemical compound COC1=CC=CC(NC=2C3=CC(NC(=O)C=C)=CC=C3N=CC=2C#N)=C1 JEVROOVJYXQOEZ-UHFFFAOYSA-N 0.000 claims description 2
- KEQGHXFVKOQNQC-UHFFFAOYSA-N n-[4-(3-bromo-4-fluoroanilino)-3-cyano-7-methoxyquinolin-6-yl]-4-morpholin-4-ylbut-2-enamide Chemical compound C=12C=C(NC(=O)C=CCN3CCOCC3)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C(Br)=C1 KEQGHXFVKOQNQC-UHFFFAOYSA-N 0.000 claims description 2
- AKTAELVLHHYTPP-UHFFFAOYSA-N n-[4-(3-bromo-4-fluoroanilino)-3-cyanoquinolin-6-yl]-4-(diethylamino)but-2-enamide Chemical compound C12=CC(NC(=O)C=CCN(CC)CC)=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(Br)=C1 AKTAELVLHHYTPP-UHFFFAOYSA-N 0.000 claims description 2
- OFGJOXKWOLGBRC-UHFFFAOYSA-N n-[4-(3-bromo-4-fluoroanilino)-3-cyanoquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound C12=CC(NC(=O)C=CCN(C)C)=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(Br)=C1 OFGJOXKWOLGBRC-UHFFFAOYSA-N 0.000 claims description 2
- SPXOEZKLWIVPKM-UHFFFAOYSA-N n-[4-(3-bromo-4-fluoroanilino)-3-cyanoquinolin-6-yl]-4-morpholin-4-ylbut-2-enamide Chemical compound C1=C(Br)C(F)=CC=C1NC(C1=C2)=C(C#N)C=NC1=CC=C2NC(=O)C=CCN1CCOCC1 SPXOEZKLWIVPKM-UHFFFAOYSA-N 0.000 claims description 2
- HKLOKSUROGEMSK-UHFFFAOYSA-N n-[4-(3-bromoanilino)-3-cyano-7-methoxyquinolin-6-yl]prop-2-enamide Chemical compound C=12C=C(NC(=O)C=C)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 HKLOKSUROGEMSK-UHFFFAOYSA-N 0.000 claims description 2
- KBJXOMLMGJAGKB-UHFFFAOYSA-N n-[4-(3-bromoanilino)-3-cyano-8-[(dimethylamino)methyl]quinolin-6-yl]acetamide Chemical compound N#CC1=CN=C2C(CN(C)C)=CC(NC(C)=O)=CC2=C1NC1=CC=CC(Br)=C1 KBJXOMLMGJAGKB-UHFFFAOYSA-N 0.000 claims description 2
- GJYOWCCGMOXTJG-UHFFFAOYSA-N n-[4-(3-bromoanilino)-3-cyano-8-[(dimethylamino)methyl]quinolin-6-yl]prop-2-enamide Chemical compound N#CC1=CN=C2C(CN(C)C)=CC(NC(=O)C=C)=CC2=C1NC1=CC=CC(Br)=C1 GJYOWCCGMOXTJG-UHFFFAOYSA-N 0.000 claims description 2
- CQFOPPHLPZNBKO-UHFFFAOYSA-N n-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]-2-(morpholin-4-ylmethyl)prop-2-enamide Chemical compound BrC1=CC=CC(NC=2C3=CC(NC(=O)C(=C)CN4CCOCC4)=CC=C3N=CC=2C#N)=C1 CQFOPPHLPZNBKO-UHFFFAOYSA-N 0.000 claims description 2
- PTSZXFBVOGOHCV-UHFFFAOYSA-N n-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]-2-chloroacetamide Chemical compound C12=CC(NC(=O)CCl)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 PTSZXFBVOGOHCV-UHFFFAOYSA-N 0.000 claims description 2
- KGUJQEYRHHBQRF-UHFFFAOYSA-N n-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]acetamide Chemical compound C12=CC(NC(=O)C)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 KGUJQEYRHHBQRF-UHFFFAOYSA-N 0.000 claims description 2
- JKBHSBZUZPGJAH-UHFFFAOYSA-N n-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]butanamide Chemical compound C12=CC(NC(=O)CCC)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 JKBHSBZUZPGJAH-UHFFFAOYSA-N 0.000 claims description 2
- MSLIBSZZLAWHQM-UHFFFAOYSA-N n-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]prop-2-enamide Chemical compound BrC1=CC=CC(NC=2C3=CC(NC(=O)C=C)=CC=C3N=CC=2C#N)=C1 MSLIBSZZLAWHQM-UHFFFAOYSA-N 0.000 claims description 2
- FZGMFMLMNGWHRX-UHFFFAOYSA-N n-[4-(3-chloro-4-fluoroanilino)-3-cyanoquinolin-6-yl]-2-(morpholin-4-ylmethyl)prop-2-enamide Chemical compound C1=C(Cl)C(F)=CC=C1NC(C1=C2)=C(C#N)C=NC1=CC=C2NC(=O)C(=C)CN1CCOCC1 FZGMFMLMNGWHRX-UHFFFAOYSA-N 0.000 claims description 2
- WZKCFGBQMSKKQQ-UHFFFAOYSA-N n-[4-(3-chloro-4-fluoroanilino)-3-cyanoquinolin-6-yl]-4-(diethylamino)but-2-enamide Chemical compound C12=CC(NC(=O)C=CCN(CC)CC)=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(Cl)=C1 WZKCFGBQMSKKQQ-UHFFFAOYSA-N 0.000 claims description 2
- KXQYGHZAGFHMDJ-UHFFFAOYSA-N n-[4-(3-chloro-4-fluoroanilino)-3-cyanoquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound C12=CC(NC(=O)C=CCN(C)C)=CC=C2N=CC(C#N)=C1NC1=CC=C(F)C(Cl)=C1 KXQYGHZAGFHMDJ-UHFFFAOYSA-N 0.000 claims description 2
- USKFPOBBUSZDCR-UHFFFAOYSA-N n-[4-(3-chloro-4-fluoroanilino)-3-cyanoquinolin-6-yl]-4-morpholin-4-ylbut-2-enamide Chemical compound C1=C(Cl)C(F)=CC=C1NC(C1=C2)=C(C#N)C=NC1=CC=C2NC(=O)C=CCN1CCOCC1 USKFPOBBUSZDCR-UHFFFAOYSA-N 0.000 claims description 2
- CYCQVROTABWGKI-UHFFFAOYSA-N n-[4-(3-chloro-4-fluoroanilino)-3-cyanoquinolin-6-yl]prop-2-enamide Chemical compound C1=C(Cl)C(F)=CC=C1NC1=C(C#N)C=NC2=CC=C(NC(=O)C=C)C=C12 CYCQVROTABWGKI-UHFFFAOYSA-N 0.000 claims description 2
- GASFMMJWWWYIBV-UHFFFAOYSA-N n-[4-(3-chloroanilino)-3-cyanoquinolin-6-yl]prop-2-enamide Chemical compound ClC1=CC=CC(NC=2C3=CC(NC(=O)C=C)=CC=C3N=CC=2C#N)=C1 GASFMMJWWWYIBV-UHFFFAOYSA-N 0.000 claims description 2
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims description 2
- 125000002112 pyrrolidino group Chemical group [*]N1C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- WMOZUHUKRDBJEF-UHFFFAOYSA-N s-[[3-[(3-cyano-6,7-dimethoxyquinolin-4-yl)amino]phenyl]methyl] ethanethioate Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(CSC(C)=O)=C1 WMOZUHUKRDBJEF-UHFFFAOYSA-N 0.000 claims description 2
- SGCYGYMSLXKPIT-UHFFFAOYSA-N 2-(3-morpholin-4-ylpropoxy)quinoline-3-carbonitrile Chemical compound N#CC1=CC2=CC=CC=C2N=C1OCCCN1CCOCC1 SGCYGYMSLXKPIT-UHFFFAOYSA-N 0.000 claims 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims 2
- NNUBNOJEKVJYEQ-UHFFFAOYSA-N 6-amino-4-[3-(dimethylamino)anilino]quinoline-3-carbonitrile Chemical compound CN(C)C1=CC=CC(NC=2C3=CC(N)=CC=C3N=CC=2C#N)=C1 NNUBNOJEKVJYEQ-UHFFFAOYSA-N 0.000 claims 2
- ATKJDNWWCUYWGP-UHFFFAOYSA-N 6-amino-4-[4-(dimethylamino)anilino]quinoline-3-carbonitrile Chemical compound C1=CC(N(C)C)=CC=C1NC1=C(C#N)C=NC2=CC=C(N)C=C12 ATKJDNWWCUYWGP-UHFFFAOYSA-N 0.000 claims 2
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- RTJPSNFGGWVYTF-UHFFFAOYSA-N 2-(4-bromoanilino)-6-nitroquinoline-3-carbonitrile Chemical compound N#CC1=CC2=CC([N+](=O)[O-])=CC=C2N=C1NC1=CC=C(Br)C=C1 RTJPSNFGGWVYTF-UHFFFAOYSA-N 0.000 claims 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims 1
- 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 claims 1
- TZNVNORLQOCTMY-UHFFFAOYSA-N 4-(2,4-dihydroxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(O)C=C1O TZNVNORLQOCTMY-UHFFFAOYSA-N 0.000 claims 1
- FNAOGFPOADZWDT-UHFFFAOYSA-N 4-(2-amino-4,5-dimethylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC(C)=C(C)C=C1N FNAOGFPOADZWDT-UHFFFAOYSA-N 0.000 claims 1
- GGSWVTQHMOCNJI-UHFFFAOYSA-N 4-(2-chloro-4-hydroxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(O)C=C1Cl GGSWVTQHMOCNJI-UHFFFAOYSA-N 0.000 claims 1
- VVWPJQJYFBFVJH-UHFFFAOYSA-N 4-(2-hydroxy-4-methylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(C)C=C1O VVWPJQJYFBFVJH-UHFFFAOYSA-N 0.000 claims 1
- QUSXJYUXWFSQPQ-UHFFFAOYSA-N 4-(2-hydroxy-5-methylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC(C)=CC=C1O QUSXJYUXWFSQPQ-UHFFFAOYSA-N 0.000 claims 1
- LNBBTBLPDKHCPQ-UHFFFAOYSA-N 4-(3,4-dichloroanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=C(Cl)C(Cl)=C1 LNBBTBLPDKHCPQ-UHFFFAOYSA-N 0.000 claims 1
- MBEJRIMUDFCZSL-UHFFFAOYSA-N 4-(3,5-dibromo-4-hydroxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC(Br)=C(O)C(Br)=C1 MBEJRIMUDFCZSL-UHFFFAOYSA-N 0.000 claims 1
- YJBYKRFNOYCMSK-UHFFFAOYSA-N 4-(3,5-dichloro-4-hydroxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC(Cl)=C(O)C(Cl)=C1 YJBYKRFNOYCMSK-UHFFFAOYSA-N 0.000 claims 1
- PVGQFSJIEXPGDS-UHFFFAOYSA-N 4-(3-azidoanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(N=[N+]=[N-])=C1 PVGQFSJIEXPGDS-UHFFFAOYSA-N 0.000 claims 1
- NVHCPPNJEXAXNA-UHFFFAOYSA-N 4-(3-bromoanilino)-6,7-bis(2-methoxyethoxy)quinoline-3-carbonitrile Chemical compound C=12C=C(OCCOC)C(OCCOC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 NVHCPPNJEXAXNA-UHFFFAOYSA-N 0.000 claims 1
- PADYONKQSSWAFW-UHFFFAOYSA-N 4-(3-bromoanilino)-6,7-dibutoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCCCC)C(OCCCC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 PADYONKQSSWAFW-UHFFFAOYSA-N 0.000 claims 1
- LRIHFKGXXJKDDD-UHFFFAOYSA-N 4-(3-bromoanilino)-6,7-dipropoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCCC)C(OCCC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 LRIHFKGXXJKDDD-UHFFFAOYSA-N 0.000 claims 1
- BWXDTMBEXXDSQD-UHFFFAOYSA-N 4-(3-bromoanilino)-6-(3-pyrrolidin-1-ylpropylamino)quinoline-3-carbonitrile Chemical compound BrC1=CC=CC(NC=2C3=CC(NCCCN4CCCC4)=CC=C3N=CC=2C#N)=C1 BWXDTMBEXXDSQD-UHFFFAOYSA-N 0.000 claims 1
- MCIICVWNGVSLPW-UHFFFAOYSA-N 4-(3-bromoanilino)-6-(dimethylamino)quinoline-3-carbonitrile;hydrochloride Chemical compound Cl.C12=CC(N(C)C)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 MCIICVWNGVSLPW-UHFFFAOYSA-N 0.000 claims 1
- IYPAMCYSGUYVAN-UHFFFAOYSA-N 4-(3-bromoanilino)-6-methoxy-7-(3-morpholin-4-ylpropoxy)quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1NC1=CC=CC(Br)=C1 IYPAMCYSGUYVAN-UHFFFAOYSA-N 0.000 claims 1
- QHDFGPMRPDDNDN-UHFFFAOYSA-N 4-(3-bromoanilino)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinoline-3-carbonitrile Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 QHDFGPMRPDDNDN-UHFFFAOYSA-N 0.000 claims 1
- PYGUWPNNELOZLP-UHFFFAOYSA-N 4-(3-bromoanilino)-8-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=CC2=C1NC1=CC=CC(Br)=C1 PYGUWPNNELOZLP-UHFFFAOYSA-N 0.000 claims 1
- OPYYYPKXOUKXEH-UHFFFAOYSA-N 4-(3-chloro-4-fluoroanilino)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinoline-3-carbonitrile Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C(Cl)=C1 OPYYYPKXOUKXEH-UHFFFAOYSA-N 0.000 claims 1
- OTTMSKLASSZGJD-UHFFFAOYSA-N 4-(3-chloro-4-methoxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C1=C(Cl)C(OC)=CC=C1NC1=C(C#N)C=NC2=CC(OC)=C(OC)C=C12 OTTMSKLASSZGJD-UHFFFAOYSA-N 0.000 claims 1
- OSNTXNDDUYHOPC-UHFFFAOYSA-N 4-(3-chloro-4-methylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(C)C(Cl)=C1 OSNTXNDDUYHOPC-UHFFFAOYSA-N 0.000 claims 1
- ZFLQLVUBCSNBJL-UHFFFAOYSA-N 4-(3-fluoroanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=CC(F)=C1 ZFLQLVUBCSNBJL-UHFFFAOYSA-N 0.000 claims 1
- WAJLIMOCEJPQKH-UHFFFAOYSA-N 4-(3-hydroxy-4-methoxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C1=C(O)C(OC)=CC=C1NC1=C(C#N)C=NC2=CC(OC)=C(OC)C=C12 WAJLIMOCEJPQKH-UHFFFAOYSA-N 0.000 claims 1
- ORXRAXFKEQIAIH-UHFFFAOYSA-N 4-(3-hydroxy-4-methoxyanilino)-8-methoxy-6-nitroquinoline-3-carbonitrile Chemical compound C1=C(O)C(OC)=CC=C1NC1=C(C#N)C=NC2=C(OC)C=C([N+]([O-])=O)C=C12 ORXRAXFKEQIAIH-UHFFFAOYSA-N 0.000 claims 1
- GOYDWBWGOZQPPQ-UHFFFAOYSA-N 4-(3-hydroxy-4-methoxyanilino)-8-methoxyquinoline-3-carbonitrile Chemical compound C1=C(O)C(OC)=CC=C1NC1=C(C#N)C=NC2=C(OC)C=CC=C12 GOYDWBWGOZQPPQ-UHFFFAOYSA-N 0.000 claims 1
- CCGQJNCMOBQUDD-UHFFFAOYSA-N 4-(3-hydroxy-4-methylanilino)-6-methoxyquinoline-3-carbonitrile Chemical compound C12=CC(OC)=CC=C2N=CC(C#N)=C1NC1=CC=C(C)C(O)=C1 CCGQJNCMOBQUDD-UHFFFAOYSA-N 0.000 claims 1
- ILIFRLHRZPLVLV-UHFFFAOYSA-N 4-(3-hydroxy-4-methylanilino)-7-methoxyquinoline-3-carbonitrile Chemical compound N#CC=1C=NC2=CC(OC)=CC=C2C=1NC1=CC=C(C)C(O)=C1 ILIFRLHRZPLVLV-UHFFFAOYSA-N 0.000 claims 1
- RFRODPJRPJJUKI-UHFFFAOYSA-N 4-(3-hydroxy-4-methylanilino)-8-methoxy-6-nitroquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC([N+]([O-])=O)=CC2=C1NC1=CC=C(C)C(O)=C1 RFRODPJRPJJUKI-UHFFFAOYSA-N 0.000 claims 1
- QPFBREGJTDLPBW-UHFFFAOYSA-N 4-(3-hydroxy-4-methylanilino)-8-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=CC2=C1NC1=CC=C(C)C(O)=C1 QPFBREGJTDLPBW-UHFFFAOYSA-N 0.000 claims 1
- IKUBPVIBISSEJV-UHFFFAOYSA-N 4-(3-hydroxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(O)=C1 IKUBPVIBISSEJV-UHFFFAOYSA-N 0.000 claims 1
- FHZKUQUEIDJHNY-UHFFFAOYSA-N 4-(3-methylsulfanylanilino)-6-nitroquinoline-3-carbonitrile Chemical compound CSC1=CC=CC(NC=2C3=CC(=CC=C3N=CC=2C#N)[N+]([O-])=O)=C1 FHZKUQUEIDJHNY-UHFFFAOYSA-N 0.000 claims 1
- UFBPAPKMTIFMAC-UHFFFAOYSA-N 4-(4-bromo-3-hydroxyanilino)-8-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=CC2=C1NC1=CC=C(Br)C(O)=C1 UFBPAPKMTIFMAC-UHFFFAOYSA-N 0.000 claims 1
- CPMQZDLBPYFFLC-UHFFFAOYSA-N 4-(4-chloro-2-fluoro-5-hydroxyanilino)-6-methoxyquinoline-3-carbonitrile Chemical compound C12=CC(OC)=CC=C2N=CC(C#N)=C1NC1=CC(O)=C(Cl)C=C1F CPMQZDLBPYFFLC-UHFFFAOYSA-N 0.000 claims 1
- AWVIKPDIAVKVTD-UHFFFAOYSA-N 4-(4-chloro-2-fluoro-5-hydroxyanilino)-7-methoxyquinoline-3-carbonitrile Chemical compound N#CC=1C=NC2=CC(OC)=CC=C2C=1NC1=CC(O)=C(Cl)C=C1F AWVIKPDIAVKVTD-UHFFFAOYSA-N 0.000 claims 1
- AGDGNPMRBLYEBN-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-6,7-dihydroxyquinoline-3-carbonitrile Chemical compound C=12C=C(O)C(O)=CC2=NC=C(C#N)C=1NC1=CC=C(Cl)C=C1F AGDGNPMRBLYEBN-UHFFFAOYSA-N 0.000 claims 1
- QDMNXRDMMAATAQ-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-6-methoxy-7-phenylmethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCC=3C=CC=CC=3)C(OC)=CC2=C1NC1=CC=C(Cl)C=C1F QDMNXRDMMAATAQ-UHFFFAOYSA-N 0.000 claims 1
- WGZXUJZAMNFXSU-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-6-methoxyquinoline-3-carbonitrile Chemical compound C12=CC(OC)=CC=C2N=CC(C#N)=C1NC1=CC=C(Cl)C=C1F WGZXUJZAMNFXSU-UHFFFAOYSA-N 0.000 claims 1
- JSZSIBBREFGLGJ-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-7-ethoxyquinoline-3-carbonitrile Chemical compound N#CC=1C=NC2=CC(OCC)=CC=C2C=1NC1=CC=C(Cl)C=C1F JSZSIBBREFGLGJ-UHFFFAOYSA-N 0.000 claims 1
- NBFFJZSLOQTJKX-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-7-hydroxyquinoline-3-carbonitrile Chemical compound N#CC=1C=NC2=CC(O)=CC=C2C=1NC1=CC=C(Cl)C=C1F NBFFJZSLOQTJKX-UHFFFAOYSA-N 0.000 claims 1
- UFUCDVGCMNVASM-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinoline-3-carbonitrile Chemical compound C=12C=C(OCCCN3CCOCC3)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(Cl)C=C1F UFUCDVGCMNVASM-UHFFFAOYSA-N 0.000 claims 1
- RWPARJNAESKYRJ-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-7-methoxy-6-nitroquinoline-3-carbonitrile Chemical compound C=12C=C([N+]([O-])=O)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(Cl)C=C1F RWPARJNAESKYRJ-UHFFFAOYSA-N 0.000 claims 1
- NIFSUEUBPCVATA-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-7-methoxyquinoline-3-carbonitrile Chemical compound N#CC=1C=NC2=CC(OC)=CC=C2C=1NC1=CC=C(Cl)C=C1F NIFSUEUBPCVATA-UHFFFAOYSA-N 0.000 claims 1
- VUELXWCNULTVCB-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-8-methoxy-6-nitroquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC([N+]([O-])=O)=CC2=C1NC1=CC=C(Cl)C=C1F VUELXWCNULTVCB-UHFFFAOYSA-N 0.000 claims 1
- VHNUHNWRNYABHC-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-8-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=CC2=C1NC1=CC=C(Cl)C=C1F VHNUHNWRNYABHC-UHFFFAOYSA-N 0.000 claims 1
- INWVUMKNCRPNHB-UHFFFAOYSA-N 4-(4-chloro-2-methylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(Cl)C=C1C INWVUMKNCRPNHB-UHFFFAOYSA-N 0.000 claims 1
- HLURNMSMPHQXLV-UHFFFAOYSA-N 4-(4-ethylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C1=CC(CC)=CC=C1NC1=C(C#N)C=NC2=CC(OC)=C(OC)C=C12 HLURNMSMPHQXLV-UHFFFAOYSA-N 0.000 claims 1
- NAPDTERTUWQXNR-UHFFFAOYSA-N 4-(4-hydroxy-2-methylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(O)C=C1C NAPDTERTUWQXNR-UHFFFAOYSA-N 0.000 claims 1
- ACACRWSZUZUTEJ-UHFFFAOYSA-N 4-(4-hydroxy-2-methylanilino)-6-methoxy-7-(3-morpholin-4-ylpropoxy)quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1NC1=CC=C(O)C=C1C ACACRWSZUZUTEJ-UHFFFAOYSA-N 0.000 claims 1
- OQUDHJHVQGCUOJ-UHFFFAOYSA-N 4-(4-hydroxy-3,5-dimethylanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC(C)=C(O)C(C)=C1 OQUDHJHVQGCUOJ-UHFFFAOYSA-N 0.000 claims 1
- IVWBIVZBYRCUFO-UHFFFAOYSA-N 4-(5-chloro-2-hydroxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC(Cl)=CC=C1O IVWBIVZBYRCUFO-UHFFFAOYSA-N 0.000 claims 1
- PAOLEDZAKLCSFE-UHFFFAOYSA-N 4-(5-chloro-2-methoxyanilino)-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound COC1=CC=C(Cl)C=C1NC1=C(C#N)C=NC2=CC(OC)=C(OC)C=C12 PAOLEDZAKLCSFE-UHFFFAOYSA-N 0.000 claims 1
- UATCEBVVGUUBAF-UHFFFAOYSA-N 4-[(2-aminophenyl)methylamino]-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NCC1=CC=CC=C1N UATCEBVVGUUBAF-UHFFFAOYSA-N 0.000 claims 1
- UNVQEGYJIRTKEA-UHFFFAOYSA-N 4-[(3,4-difluorophenyl)methylamino]-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NCC1=CC=C(F)C(F)=C1 UNVQEGYJIRTKEA-UHFFFAOYSA-N 0.000 claims 1
- JVPPPJVZGREELP-UHFFFAOYSA-N 4-[2-(2-hydroxyethyl)anilino]-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC=C1CCO JVPPPJVZGREELP-UHFFFAOYSA-N 0.000 claims 1
- OLPCFXOXZCAXNQ-UHFFFAOYSA-N 4-[3-(dimethylamino)anilino]-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(N(C)C)=C1 OLPCFXOXZCAXNQ-UHFFFAOYSA-N 0.000 claims 1
- LFDLSQQIFSWTPB-UHFFFAOYSA-N 4-[3-(dimethylamino)anilino]-6-nitroquinoline-3-carbonitrile Chemical compound CN(C)C1=CC=CC(NC=2C3=CC(=CC=C3N=CC=2C#N)[N+]([O-])=O)=C1 LFDLSQQIFSWTPB-UHFFFAOYSA-N 0.000 claims 1
- OGLPBSWSMKAWCR-UHFFFAOYSA-N 4-[3-(dimethylamino)anilino]-8-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=CC2=C1NC1=CC=CC(N(C)C)=C1 OGLPBSWSMKAWCR-UHFFFAOYSA-N 0.000 claims 1
- VEWKMHYYBJASDM-UHFFFAOYSA-N 4-[3-(hydroxymethyl)-2-methylanilino]-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(CO)=C1C VEWKMHYYBJASDM-UHFFFAOYSA-N 0.000 claims 1
- ZTHKSSJRIANSFO-UHFFFAOYSA-N 4-[4-(2-hydroxyethyl)anilino]-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(CCO)C=C1 ZTHKSSJRIANSFO-UHFFFAOYSA-N 0.000 claims 1
- JPFSELHYKCHNJV-UHFFFAOYSA-N 4-[4-(dimethylamino)anilino]-6-nitroquinoline-3-carbonitrile Chemical compound C1=CC(N(C)C)=CC=C1NC1=C(C#N)C=NC2=CC=C([N+]([O-])=O)C=C12 JPFSELHYKCHNJV-UHFFFAOYSA-N 0.000 claims 1
- VSEAWQWXSBESSQ-UHFFFAOYSA-N 4-[4-chloro-3-(trifluoromethyl)anilino]-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(Cl)C(C(F)(F)F)=C1 VSEAWQWXSBESSQ-UHFFFAOYSA-N 0.000 claims 1
- YYARKMZWFMYHGW-UHFFFAOYSA-N 4-bromo-n-[4-(3-bromo-4-fluoroanilino)-3-cyano-7-methoxyquinolin-6-yl]but-2-enamide Chemical compound C=12C=C(NC(=O)C=CCBr)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C(Br)=C1 YYARKMZWFMYHGW-UHFFFAOYSA-N 0.000 claims 1
- IZQHULBHKPGOAP-UHFFFAOYSA-N 4-n-(3-bromophenyl)quinazoline-4,6-diamine Chemical compound C12=CC(N)=CC=C2N=CN=C1NC1=CC=CC(Br)=C1 IZQHULBHKPGOAP-UHFFFAOYSA-N 0.000 claims 1
- ZSJDOQUXSFYFRM-UHFFFAOYSA-N 6,7-dimethoxy-4-(3-methylsulfanylanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(SC)=C1 ZSJDOQUXSFYFRM-UHFFFAOYSA-N 0.000 claims 1
- VVHLRJCWFVPVSW-UHFFFAOYSA-N 6,7-dimethoxy-4-(3-phenoxyanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC(C=1)=CC=CC=1OC1=CC=CC=C1 VVHLRJCWFVPVSW-UHFFFAOYSA-N 0.000 claims 1
- PLZHSFDPFHDSRA-UHFFFAOYSA-N 6,7-dimethoxy-4-(4-methoxy-2-methylanilino)quinoline-3-carbonitrile Chemical compound CC1=CC(OC)=CC=C1NC1=C(C#N)C=NC2=CC(OC)=C(OC)C=C12 PLZHSFDPFHDSRA-UHFFFAOYSA-N 0.000 claims 1
- JXLUYPNXIHHINO-UHFFFAOYSA-N 6,7-dimethoxy-4-(4-methylanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(C)C=C1 JXLUYPNXIHHINO-UHFFFAOYSA-N 0.000 claims 1
- DRHDIJVDQNOQEI-UHFFFAOYSA-N 6,7-dimethoxy-4-(4-methylsulfanylanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(SC)C=C1 DRHDIJVDQNOQEI-UHFFFAOYSA-N 0.000 claims 1
- GSVIQADQNZROAL-UHFFFAOYSA-N 6,7-dimethoxy-4-(4-phenoxyanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC(C=C1)=CC=C1OC1=CC=CC=C1 GSVIQADQNZROAL-UHFFFAOYSA-N 0.000 claims 1
- LYWXXIOBMCQLNJ-UHFFFAOYSA-N 6,7-dimethoxy-4-(pyridin-3-ylamino)quinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CN=C1 LYWXXIOBMCQLNJ-UHFFFAOYSA-N 0.000 claims 1
- WHMRDYJJAXPWGX-UHFFFAOYSA-N 6,7-dimethoxy-4-[4-(trifluoromethyl)anilino]quinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(C(F)(F)F)C=C1 WHMRDYJJAXPWGX-UHFFFAOYSA-N 0.000 claims 1
- MTPYYINKVPVYNQ-UHFFFAOYSA-N 6-(dimethylamino)-4-(3-methoxyanilino)quinoline-3-carbonitrile;hydrochloride Chemical compound Cl.COC1=CC=CC(NC=2C3=CC(=CC=C3N=CC=2C#N)N(C)C)=C1 MTPYYINKVPVYNQ-UHFFFAOYSA-N 0.000 claims 1
- BCAYGAKYRNJRSZ-UHFFFAOYSA-N 6-amino-4-(3-hydroxy-4-methoxyanilino)-8-methoxyquinoline-3-carbonitrile Chemical compound C1=C(O)C(OC)=CC=C1NC1=C(C#N)C=NC2=C(OC)C=C(N)C=C12 BCAYGAKYRNJRSZ-UHFFFAOYSA-N 0.000 claims 1
- DWJCHBHBLILFOB-UHFFFAOYSA-N 6-amino-4-(3-hydroxy-4-methylanilino)-8-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC(N)=CC2=C1NC1=CC=C(C)C(O)=C1 DWJCHBHBLILFOB-UHFFFAOYSA-N 0.000 claims 1
- IHOAIURDVZHDEQ-UHFFFAOYSA-N 6-amino-4-(3-methylsulfanylanilino)quinoline-3-carbonitrile Chemical compound CSC1=CC=CC(NC=2C3=CC(N)=CC=C3N=CC=2C#N)=C1 IHOAIURDVZHDEQ-UHFFFAOYSA-N 0.000 claims 1
- BPRJKKPJMZUBDG-UHFFFAOYSA-N 6-amino-4-(3-propan-2-ylanilino)quinoline-3-carbonitrile Chemical compound CC(C)C1=CC=CC(NC=2C3=CC(N)=CC=C3N=CC=2C#N)=C1 BPRJKKPJMZUBDG-UHFFFAOYSA-N 0.000 claims 1
- VPGQEKLTHYYHRA-UHFFFAOYSA-N 6-amino-4-(4-chloro-2-fluoroanilino)-7-methoxyquinoline-3-carbonitrile Chemical compound C=12C=C(N)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=C(Cl)C=C1F VPGQEKLTHYYHRA-UHFFFAOYSA-N 0.000 claims 1
- WPUZJCWFDMOJQH-UHFFFAOYSA-N 6-iodo-4-(3-methoxyanilino)quinoline-3-carbonitrile Chemical compound COC1=CC=CC(NC=2C3=CC(I)=CC=C3N=CC=2C#N)=C1 WPUZJCWFDMOJQH-UHFFFAOYSA-N 0.000 claims 1
- WCOAJGXFODNEJR-UHFFFAOYSA-N 6-methoxy-4-(2-methylsulfanylanilino)-7-(3-morpholin-4-ylpropoxy)quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCN3CCOCC3)C(OC)=CC2=C1NC1=CC=CC=C1SC WCOAJGXFODNEJR-UHFFFAOYSA-N 0.000 claims 1
- HZFKBQSCERCMGV-UHFFFAOYSA-N 6-nitro-4-(3-propan-2-ylanilino)quinoline-3-carbonitrile Chemical compound CC(C)C1=CC=CC(NC=2C3=CC(=CC=C3N=CC=2C#N)[N+]([O-])=O)=C1 HZFKBQSCERCMGV-UHFFFAOYSA-N 0.000 claims 1
- CRYQEVRYEJPICG-UHFFFAOYSA-N 6-nitro-4-[3-(trifluoromethoxy)anilino]quinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=CC(OC(F)(F)F)=C1 CRYQEVRYEJPICG-UHFFFAOYSA-N 0.000 claims 1
- OMJZUXOYCMTLLW-UHFFFAOYSA-N 8-methoxy-4-(2,4,6-trifluoroanilino)quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=CC2=C1NC1=C(F)C=C(F)C=C1F OMJZUXOYCMTLLW-UHFFFAOYSA-N 0.000 claims 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims 1
- WXZKIKQSGYISMT-UHFFFAOYSA-N ClC=1C(=C(C=CC=1)NC1=C(C=NC2=CC=C(C=C12)NC(C=C)=O)C#N)OC=1C=CSC=1 Chemical compound ClC=1C(=C(C=CC=1)NC1=C(C=NC2=CC=C(C=C12)NC(C=C)=O)C#N)OC=1C=CSC=1 WXZKIKQSGYISMT-UHFFFAOYSA-N 0.000 claims 1
- WXYBQHVGNHSYBJ-UHFFFAOYSA-N N-(3-bromophenyl)-N-(3-cyano-6,7-dihydroxyquinolin-4-yl)acetamide Chemical compound N#CC=1C=NC2=CC(O)=C(O)C=C2C=1N(C(=O)C)C1=CC=CC(Br)=C1 WXYBQHVGNHSYBJ-UHFFFAOYSA-N 0.000 claims 1
- 125000000066 S-methyl group Chemical group [H]C([H])([H])S* 0.000 claims 1
- MQWPQDJSSWDVTQ-UHFFFAOYSA-N n-[3-cyano-4-(3-propan-2-ylanilino)quinolin-6-yl]prop-2-enamide Chemical compound CC(C)C1=CC=CC(NC=2C3=CC(NC(=O)C=C)=CC=C3N=CC=2C#N)=C1 MQWPQDJSSWDVTQ-UHFFFAOYSA-N 0.000 claims 1
- QSMHWFXKNHCJSQ-UHFFFAOYSA-N n-[3-cyano-4-[3-(dimethylamino)anilino]quinolin-6-yl]prop-2-enamide Chemical compound CN(C)C1=CC=CC(NC=2C3=CC(NC(=O)C=C)=CC=C3N=CC=2C#N)=C1 QSMHWFXKNHCJSQ-UHFFFAOYSA-N 0.000 claims 1
- JSPHYZXDFYTYMG-UHFFFAOYSA-N n-[3-cyano-4-[4-(dimethylamino)anilino]quinolin-6-yl]prop-2-enamide Chemical compound C1=CC(N(C)C)=CC=C1NC1=C(C#N)C=NC2=CC=C(NC(=O)C=C)C=C12 JSPHYZXDFYTYMG-UHFFFAOYSA-N 0.000 claims 1
- QWSSCGSSNDSGPP-UHFFFAOYSA-N n-[4-(3-bromoanilino)-3-cyano-7-methoxyquinolin-6-yl]-4-chlorobut-2-enamide Chemical compound C=12C=C(NC(=O)C=CCCl)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(Br)=C1 QWSSCGSSNDSGPP-UHFFFAOYSA-N 0.000 claims 1
- QAIWBHUZZZOVEO-UHFFFAOYSA-N n-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]propanamide Chemical compound C12=CC(NC(=O)CC)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 QAIWBHUZZZOVEO-UHFFFAOYSA-N 0.000 claims 1
- 125000004550 quinolin-6-yl group Chemical group N1=CC=CC2=CC(=CC=C12)* 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 473
- 239000000203 mixture Substances 0.000 description 346
- 239000007787 solid Substances 0.000 description 336
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 316
- 239000000243 solution Substances 0.000 description 283
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 238
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 231
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 186
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 163
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 158
- 235000019439 ethyl acetate Nutrition 0.000 description 156
- 239000002904 solvent Substances 0.000 description 154
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 147
- 238000001819 mass spectrum Methods 0.000 description 144
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 140
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 110
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 104
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 92
- 239000012299 nitrogen atmosphere Substances 0.000 description 79
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 71
- 238000010992 reflux Methods 0.000 description 69
- 239000012044 organic layer Substances 0.000 description 67
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 62
- 238000006243 chemical reaction Methods 0.000 description 62
- 239000000047 product Substances 0.000 description 62
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 57
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 57
- 235000017557 sodium bicarbonate Nutrition 0.000 description 54
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 54
- 239000000725 suspension Substances 0.000 description 49
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 48
- 239000000741 silica gel Substances 0.000 description 47
- 229910002027 silica gel Inorganic materials 0.000 description 47
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 46
- 238000003756 stirring Methods 0.000 description 44
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 37
- 239000010410 layer Substances 0.000 description 37
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 36
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 36
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 34
- 238000010438 heat treatment Methods 0.000 description 34
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 34
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 34
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 33
- 239000012298 atmosphere Substances 0.000 description 33
- 235000011152 sodium sulphate Nutrition 0.000 description 33
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 31
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 31
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 31
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 30
- 229910052938 sodium sulfate Inorganic materials 0.000 description 30
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 29
- 235000019341 magnesium sulphate Nutrition 0.000 description 29
- 238000001228 spectrum Methods 0.000 description 29
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- 239000005457 ice water Substances 0.000 description 28
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 27
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 26
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 25
- HMLOMVBFQJAMCN-UHFFFAOYSA-N 4-chloro-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C1=C(C#N)C(Cl)=C2C=C(OC)C(OC)=CC2=N1 HMLOMVBFQJAMCN-UHFFFAOYSA-N 0.000 description 24
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- 238000000034 method Methods 0.000 description 24
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 24
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 23
- 239000012267 brine Substances 0.000 description 23
- 239000000463 material Substances 0.000 description 23
- 239000011734 sodium Substances 0.000 description 23
- 229910052708 sodium Inorganic materials 0.000 description 23
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 23
- 239000012258 stirred mixture Substances 0.000 description 23
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 21
- 239000012442 inert solvent Substances 0.000 description 21
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 19
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 18
- 238000001953 recrystallisation Methods 0.000 description 18
- 239000013078 crystal Substances 0.000 description 17
- 208000037062 Polyps Diseases 0.000 description 16
- 150000008064 anhydrides Chemical class 0.000 description 16
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 16
- QRUCHOLKZVCUAH-UHFFFAOYSA-N 4-chloro-6-nitroquinoline-3-carbonitrile Chemical compound N1=CC(C#N)=C(Cl)C2=CC([N+](=O)[O-])=CC=C21 QRUCHOLKZVCUAH-UHFFFAOYSA-N 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 238000009835 boiling Methods 0.000 description 15
- 239000000706 filtrate Substances 0.000 description 15
- 229910000027 potassium carbonate Inorganic materials 0.000 description 15
- 235000011181 potassium carbonates Nutrition 0.000 description 15
- 150000003254 radicals Chemical class 0.000 description 15
- 229910000029 sodium carbonate Inorganic materials 0.000 description 15
- HRMLDEXYPNWNSJ-UHFFFAOYSA-N 4-chloro-6,7-diethoxyquinoline-3-carbonitrile Chemical compound C1=C(C#N)C(Cl)=C2C=C(OCC)C(OCC)=CC2=N1 HRMLDEXYPNWNSJ-UHFFFAOYSA-N 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 14
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 14
- 241001465754 Metazoa Species 0.000 description 14
- 235000017803 cinnamon Nutrition 0.000 description 14
- 150000004702 methyl esters Chemical class 0.000 description 14
- 238000004587 chromatography analysis Methods 0.000 description 13
- 239000011541 reaction mixture Substances 0.000 description 13
- 150000003385 sodium Chemical class 0.000 description 13
- DHYHYLGCQVVLOQ-UHFFFAOYSA-N 3-bromoaniline Chemical compound NC1=CC=CC(Br)=C1 DHYHYLGCQVVLOQ-UHFFFAOYSA-N 0.000 description 12
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 11
- 235000019270 ammonium chloride Nutrition 0.000 description 11
- 239000003054 catalyst Substances 0.000 description 11
- 229910052742 iron Inorganic materials 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 235000011150 stannous chloride Nutrition 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000012043 crude product Substances 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 9
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 9
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 8
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 8
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 8
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 239000000377 silicon dioxide Substances 0.000 description 8
- 235000009518 sodium iodide Nutrition 0.000 description 8
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 8
- ACFFAMJSFZINGL-OWOJBTEDSA-N (e)-4-bromobut-2-enoyl chloride Chemical compound ClC(=O)\C=C\CBr ACFFAMJSFZINGL-OWOJBTEDSA-N 0.000 description 7
- XUMPXASXBIBARL-UHFFFAOYSA-N 4-chloro-5,8-dimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=C(OC)C2=C1Cl XUMPXASXBIBARL-UHFFFAOYSA-N 0.000 description 7
- PEVGALUKPXHMSG-UHFFFAOYSA-N 4-chloro-6,7,8-trimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=C(OC)C(OC)=CC2=C1Cl PEVGALUKPXHMSG-UHFFFAOYSA-N 0.000 description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 7
- 208000035984 Colonic Polyps Diseases 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 6
- 102100038280 Prostaglandin G/H synthase 2 Human genes 0.000 description 6
- 108050003267 Prostaglandin G/H synthase 2 Proteins 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 6
- 239000012047 saturated solution Substances 0.000 description 6
- MHCVCKDNQYMGEX-UHFFFAOYSA-N 1,1'-biphenyl;phenoxybenzene Chemical compound C1=CC=CC=C1C1=CC=CC=C1.C=1C=CC=CC=1OC1=CC=CC=C1 MHCVCKDNQYMGEX-UHFFFAOYSA-N 0.000 description 5
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 5
- 125000006012 2-chloroethoxy group Chemical group 0.000 description 5
- CSFDTBRRIBJILD-UHFFFAOYSA-N 4-chloro-2-fluoroaniline Chemical compound NC1=CC=C(Cl)C=C1F CSFDTBRRIBJILD-UHFFFAOYSA-N 0.000 description 5
- JTNOADATUOSXCU-UHFFFAOYSA-N 4-chloro-7-methoxy-6-nitroquinoline-3-carbonitrile Chemical compound C1=C(C#N)C(Cl)=C2C=C([N+]([O-])=O)C(OC)=CC2=N1 JTNOADATUOSXCU-UHFFFAOYSA-N 0.000 description 5
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 5
- 208000004804 Adenomatous Polyps Diseases 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 5
- 125000003277 amino group Chemical group 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 235000011089 carbon dioxide Nutrition 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 5
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 5
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- IFYDWYVPVAMGRO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)NCCCN(C)C IFYDWYVPVAMGRO-UHFFFAOYSA-N 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 238000004634 pharmacological analysis method Methods 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 125000005270 trialkylamine group Chemical group 0.000 description 5
- 229940093475 2-ethoxyethanol Drugs 0.000 description 4
- YSEMCVGMNUUNRK-UHFFFAOYSA-N 3-chloro-4-fluoroaniline Chemical compound NC1=CC=C(F)C(Cl)=C1 YSEMCVGMNUUNRK-UHFFFAOYSA-N 0.000 description 4
- DOTGZROJTAUYFQ-UHFFFAOYSA-N 4-bromobut-2-enoic acid Chemical compound OC(=O)C=CCBr DOTGZROJTAUYFQ-UHFFFAOYSA-N 0.000 description 4
- QPYOVDHMXSEVCP-UHFFFAOYSA-N 4-chloro-5,6-bis(2-methoxyethoxy)quinoline-3-carbonitrile Chemical compound N1=CC(C#N)=C(Cl)C2=C(OCCOC)C(OCCOC)=CC=C21 QPYOVDHMXSEVCP-UHFFFAOYSA-N 0.000 description 4
- RLXUEEGTWNCIML-UHFFFAOYSA-N 4-chloro-6-ethoxy-7-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OC)C(OCC)=CC2=C1Cl RLXUEEGTWNCIML-UHFFFAOYSA-N 0.000 description 4
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 4
- DBFYESDCPWWCHN-UHFFFAOYSA-N 5-amino-2-methylphenol Chemical compound CC1=CC=C(N)C=C1O DBFYESDCPWWCHN-UHFFFAOYSA-N 0.000 description 4
- BRANBXSWAAPZNW-UHFFFAOYSA-N 7-methoxy-4-oxo-1h-quinoline-3-carbonitrile Chemical compound N1C=C(C#N)C(=O)C=2C1=CC(OC)=CC=2 BRANBXSWAAPZNW-UHFFFAOYSA-N 0.000 description 4
- 108700001666 APC Genes Proteins 0.000 description 4
- FZPIWJBWKMNPKU-UHFFFAOYSA-N C(C)N(CC)CC.C(C)CO.C(C)(=O)O Chemical compound C(C)N(CC)CC.C(C)CO.C(C)(=O)O FZPIWJBWKMNPKU-UHFFFAOYSA-N 0.000 description 4
- 201000005569 Gout Diseases 0.000 description 4
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 150000001409 amidines Chemical class 0.000 description 4
- 150000001721 carbon Chemical group 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- SKCNIGRBPJIUBQ-UHFFFAOYSA-N chloroform;ethyl acetate Chemical compound ClC(Cl)Cl.CCOC(C)=O SKCNIGRBPJIUBQ-UHFFFAOYSA-N 0.000 description 4
- 208000029664 classic familial adenomatous polyposis Diseases 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 4
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 description 4
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- UUSJPFFYHIDBML-UHFFFAOYSA-N 2-(dimethylaminomethylideneamino)-3,6-dimethoxybenzoic acid Chemical compound COC1=CC=C(OC)C(C(O)=O)=C1N=CN(C)C UUSJPFFYHIDBML-UHFFFAOYSA-N 0.000 description 3
- LMLMBWMYHXXDAN-UHFFFAOYSA-N 2-amino-5-ethoxy-4-methoxybenzoic acid Chemical compound CCOC1=CC(C(O)=O)=C(N)C=C1OC LMLMBWMYHXXDAN-UHFFFAOYSA-N 0.000 description 3
- LGDHZCLREKIGKJ-UHFFFAOYSA-N 3,4-dimethoxyaniline Chemical compound COC1=CC=C(N)C=C1OC LGDHZCLREKIGKJ-UHFFFAOYSA-N 0.000 description 3
- CKRNYBQUMRCICU-UHFFFAOYSA-N 3-chloro-4-phenylsulfanylaniline Chemical compound ClC1=CC(N)=CC=C1SC1=CC=CC=C1 CKRNYBQUMRCICU-UHFFFAOYSA-N 0.000 description 3
- DMSAIFTWQMXOBE-UHFFFAOYSA-M 3-ethoxy-4-methoxybenzoate Chemical compound CCOC1=CC(C([O-])=O)=CC=C1OC DMSAIFTWQMXOBE-UHFFFAOYSA-M 0.000 description 3
- LBKFGYZQBSGRHY-UHFFFAOYSA-M 3-hydroxy-4-methoxybenzoate Chemical compound COC1=CC=C(C([O-])=O)C=C1O LBKFGYZQBSGRHY-UHFFFAOYSA-M 0.000 description 3
- BZJPIQKDEGXVFG-UHFFFAOYSA-N 3-n,3-n-dimethylbenzene-1,3-diamine;hydron;dichloride Chemical compound Cl.Cl.CN(C)C1=CC=CC(N)=C1 BZJPIQKDEGXVFG-UHFFFAOYSA-N 0.000 description 3
- CISJBDCCOIMBGW-UHFFFAOYSA-N 4-(3-bromoanilino)-6,7-dimethoxyquinoline-3-carboxylic acid Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C(O)=O)C=1NC1=CC=CC(Br)=C1 CISJBDCCOIMBGW-UHFFFAOYSA-N 0.000 description 3
- JFOWIGIPQBODNP-UHFFFAOYSA-N 4-(4-chloro-2-fluoro-5-hydroxyanilino)-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCCl)C(OC)=CC2=C1NC1=CC(O)=C(Cl)C=C1F JFOWIGIPQBODNP-UHFFFAOYSA-N 0.000 description 3
- BEGHZKYNLSIHIA-UHFFFAOYSA-N 4-chloro-7-(3-chloropropoxy)-6-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCCl)C(OC)=CC2=C1Cl BEGHZKYNLSIHIA-UHFFFAOYSA-N 0.000 description 3
- QYYNVWZMCITGFR-UHFFFAOYSA-N 4-chloro-7-ethoxy-6-methoxyquinoline-3-carbonitrile Chemical compound C1=C(C#N)C(Cl)=C2C=C(OC)C(OCC)=CC2=N1 QYYNVWZMCITGFR-UHFFFAOYSA-N 0.000 description 3
- WMBCMCMNNWELKB-UHFFFAOYSA-N 4-chloro-7-methoxyquinoline-3-carbonitrile Chemical compound ClC1=C(C#N)C=NC2=CC(OC)=CC=C21 WMBCMCMNNWELKB-UHFFFAOYSA-N 0.000 description 3
- ORBNORBNTUFCFT-UHFFFAOYSA-N 5,8-dimethoxy-4-oxo-1h-quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC=C(OC)C2=C1O ORBNORBNTUFCFT-UHFFFAOYSA-N 0.000 description 3
- HVTHICJFQQKQDW-UHFFFAOYSA-M 5-ethoxy-4-methoxy-2-nitrobenzoate Chemical compound CCOC1=CC(C([O-])=O)=C([N+]([O-])=O)C=C1OC HVTHICJFQQKQDW-UHFFFAOYSA-M 0.000 description 3
- QTRNLGSLYVLFAW-UHFFFAOYSA-N 6,7,8-trimethoxy-4-oxo-1h-quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=C(OC)C(OC)=CC2=C1O QTRNLGSLYVLFAW-UHFFFAOYSA-N 0.000 description 3
- MQGQSQDWNVXHPH-UHFFFAOYSA-N 6-ethoxy-7-methoxy-4-oxo-1h-quinoline-3-carbonitrile Chemical compound N1C=C(C#N)C(=O)C2=C1C=C(OC)C(OCC)=C2 MQGQSQDWNVXHPH-UHFFFAOYSA-N 0.000 description 3
- AVGNNBHAGCJWPB-UHFFFAOYSA-N 7-(2-chloroethoxy)-4-(3-hydroxy-4-methylanilino)-6-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCl)C(OC)=CC2=C1NC1=CC=C(C)C(O)=C1 AVGNNBHAGCJWPB-UHFFFAOYSA-N 0.000 description 3
- TZUYFSIHNJIPJB-UHFFFAOYSA-N 7-(2-chloroethoxy)-4-(4-chloro-2-fluoro-5-hydroxyanilino)-6-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCl)C(OC)=CC2=C1NC1=CC(O)=C(Cl)C=C1F TZUYFSIHNJIPJB-UHFFFAOYSA-N 0.000 description 3
- KTZRTSATHWBRBI-UHFFFAOYSA-N 7-methoxy-6-nitro-4-oxo-1h-quinoline-3-carbonitrile Chemical compound N1C=C(C#N)C(=O)C2=C1C=C(OC)C([N+]([O-])=O)=C2 KTZRTSATHWBRBI-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 201000006107 Familial adenomatous polyposis Diseases 0.000 description 3
- 208000032177 Intestinal Polyps Diseases 0.000 description 3
- 125000005118 N-alkylcarbamoyl group Chemical group 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- VZGDMQKNWNREIO-UHFFFAOYSA-N carbon tetrachloride Substances ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- LBKFGYZQBSGRHY-UHFFFAOYSA-N iso-vanillic acid Natural products COC1=CC=C(C(O)=O)C=C1O LBKFGYZQBSGRHY-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910017604 nitric acid Inorganic materials 0.000 description 3
- 230000000737 periodic effect Effects 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- QZZYYBQGTSGDPP-UHFFFAOYSA-N quinoline-3-carbonitrile Chemical class C1=CC=CC2=CC(C#N)=CN=C21 QZZYYBQGTSGDPP-UHFFFAOYSA-N 0.000 description 3
- DJXNJVFEFSWHLY-UHFFFAOYSA-N quinoline-3-carboxylic acid Chemical compound C1=CC=CC2=CC(C(=O)O)=CN=C21 DJXNJVFEFSWHLY-UHFFFAOYSA-N 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- MLKXDPUZXIRXEP-MFOYZWKCSA-N sulindac Chemical compound CC1=C(CC(O)=O)C2=CC(F)=CC=C2\C1=C/C1=CC=C(S(C)=O)C=C1 MLKXDPUZXIRXEP-MFOYZWKCSA-N 0.000 description 3
- 229960000894 sulindac Drugs 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- OJZQOQNSUZLSMV-UHFFFAOYSA-N (3-aminophenyl)methanol Chemical compound NC1=CC=CC(CO)=C1 OJZQOQNSUZLSMV-UHFFFAOYSA-N 0.000 description 2
- ITGIYLMMAABTHC-ONEGZZNKSA-N (e)-4-(dimethylazaniumyl)but-2-enoate Chemical compound CN(C)C\C=C\C(O)=O ITGIYLMMAABTHC-ONEGZZNKSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- HFOIYVWHIPNTIJ-UHFFFAOYSA-N 2-amino-4-ethoxy-5-methoxybenzoic acid Chemical compound CCOC1=CC(N)=C(C(O)=O)C=C1OC HFOIYVWHIPNTIJ-UHFFFAOYSA-N 0.000 description 2
- WNRMLIGSXULUPQ-UHFFFAOYSA-N 2-oxo-1h-quinoline-3-carbonitrile Chemical class C1=CC=C2C=C(C#N)C(=O)NC2=C1 WNRMLIGSXULUPQ-UHFFFAOYSA-N 0.000 description 2
- CKQHAYFOPRIUOM-UHFFFAOYSA-N 3'-Aminoacetophenone Chemical compound CC(=O)C1=CC=CC(N)=C1 CKQHAYFOPRIUOM-UHFFFAOYSA-N 0.000 description 2
- VIUDTWATMPPKEL-UHFFFAOYSA-N 3-(trifluoromethyl)aniline Chemical compound NC1=CC=CC(C(F)(F)F)=C1 VIUDTWATMPPKEL-UHFFFAOYSA-N 0.000 description 2
- SFJYOSIAYPFZDP-UHFFFAOYSA-N 3-[(3-cyano-6,7-dimethoxyquinolin-4-yl)amino]benzamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1NC1=CC=CC(C(N)=O)=C1 SFJYOSIAYPFZDP-UHFFFAOYSA-N 0.000 description 2
- NJXPYZHXZZCTNI-UHFFFAOYSA-N 3-aminobenzonitrile Chemical compound NC1=CC=CC(C#N)=C1 NJXPYZHXZZCTNI-UHFFFAOYSA-N 0.000 description 2
- KOWPUNQBGWIERF-UHFFFAOYSA-N 3-bromo-4-fluoroaniline Chemical compound NC1=CC=C(F)C(Br)=C1 KOWPUNQBGWIERF-UHFFFAOYSA-N 0.000 description 2
- PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 2
- AMKPQMFZCBTTAT-UHFFFAOYSA-N 3-ethylaniline Chemical compound CCC1=CC=CC(N)=C1 AMKPQMFZCBTTAT-UHFFFAOYSA-N 0.000 description 2
- SMPOMXVCIHTEMB-UHFFFAOYSA-N 4-(3-bromoanilino)-6,7-dimethoxyquinoline-3-carboxamide Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C(N)=O)C=1NC1=CC=CC(Br)=C1 SMPOMXVCIHTEMB-UHFFFAOYSA-N 0.000 description 2
- UPVMZZFPPIIRKJ-UHFFFAOYSA-N 4-(4-bromoanilino)-6-nitroquinoline-3-carbonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2N=CC(C#N)=C1NC1=CC=C(Br)C=C1 UPVMZZFPPIIRKJ-UHFFFAOYSA-N 0.000 description 2
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 2
- GAOYRWYHERKJQE-UHFFFAOYSA-N 4-chloro-7-(2-chloroethoxy)-6-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCl)C(OC)=CC2=C1Cl GAOYRWYHERKJQE-UHFFFAOYSA-N 0.000 description 2
- PTCUBEZCMHJCMK-UHFFFAOYSA-N 4-chloro-7-ethoxy-6-nitroquinoline-3-carbonitrile Chemical compound C1=C(C#N)C(Cl)=C2C=C([N+]([O-])=O)C(OCC)=CC2=N1 PTCUBEZCMHJCMK-UHFFFAOYSA-N 0.000 description 2
- QEYAMZRQGHAJKB-UHFFFAOYSA-N 4-chloro-8-methoxy-6-nitroquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC([N+]([O-])=O)=CC2=C1Cl QEYAMZRQGHAJKB-UHFFFAOYSA-N 0.000 description 2
- OPAVQHRMPKMRFQ-UHFFFAOYSA-N 4-chloro-8-methyl-6-nitroquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(C)=CC([N+]([O-])=O)=CC2=C1Cl OPAVQHRMPKMRFQ-UHFFFAOYSA-N 0.000 description 2
- LBYKODYNFRCBIR-UHFFFAOYSA-M 4-ethoxy-3-methoxybenzoate Chemical compound CCOC1=CC=C(C([O-])=O)C=C1OC LBYKODYNFRCBIR-UHFFFAOYSA-M 0.000 description 2
- RBNLMAXLHADNEU-UHFFFAOYSA-N 4-oxo-1h-quinoline-3-carbonitrile Chemical compound C1=CC=C2C(=O)C(C#N)=CNC2=C1 RBNLMAXLHADNEU-UHFFFAOYSA-N 0.000 description 2
- AFZLCOLNTRPSIF-UHFFFAOYSA-N 5-amino-2-chloro-4-fluorophenol Chemical compound NC1=CC(O)=C(Cl)C=C1F AFZLCOLNTRPSIF-UHFFFAOYSA-N 0.000 description 2
- VZJDHPYFCBLKGI-UHFFFAOYSA-N 6,7-dimethoxy-4-oxo-1h-quinoline-3-carbonitrile Chemical compound N1C=C(C#N)C(=O)C2=C1C=C(OC)C(OC)=C2 VZJDHPYFCBLKGI-UHFFFAOYSA-N 0.000 description 2
- TUVSLUWYBFYQLA-UHFFFAOYSA-N 7-(3-chloropropoxy)-6-methoxy-4-oxo-1h-quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCCl)C(OC)=CC2=C1O TUVSLUWYBFYQLA-UHFFFAOYSA-N 0.000 description 2
- KCRWFINJQDRSKE-UHFFFAOYSA-N 7-ethoxy-4-oxo-1h-quinoline-3-carbonitrile Chemical compound OC1=C(C#N)C=NC2=CC(OCC)=CC=C21 KCRWFINJQDRSKE-UHFFFAOYSA-N 0.000 description 2
- XYYZLOVSXBIDIM-UHFFFAOYSA-N 7-ethoxy-6-methoxy-4-oxo-1h-quinoline-3-carbonitrile Chemical compound N1C=C(C#N)C(=O)C2=C1C=C(OCC)C(OC)=C2 XYYZLOVSXBIDIM-UHFFFAOYSA-N 0.000 description 2
- YWXULSPHZDNVAN-UHFFFAOYSA-N 7-ethoxy-6-nitro-4-oxo-1h-quinoline-3-carbonitrile Chemical compound C1=C(C#N)C(O)=C2C=C([N+]([O-])=O)C(OCC)=CC2=N1 YWXULSPHZDNVAN-UHFFFAOYSA-N 0.000 description 2
- JCEPZAWNXDUVPK-UHFFFAOYSA-N 8-methoxy-6-nitro-4-oxo-1h-quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C(OC)=CC([N+]([O-])=O)=CC2=C1O JCEPZAWNXDUVPK-UHFFFAOYSA-N 0.000 description 2
- 208000003200 Adenoma Diseases 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- NUJDMNVAHLIVAL-UHFFFAOYSA-N C(OC)(O)=O.ClC1=CC(=C(N)C=C1O)F Chemical compound C(OC)(O)=O.ClC1=CC(=C(N)C=C1O)F NUJDMNVAHLIVAL-UHFFFAOYSA-N 0.000 description 2
- 229940124638 COX inhibitor Drugs 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Natural products COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 230000003113 alkalizing effect Effects 0.000 description 2
- 125000000033 alkoxyamino group Chemical group 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000538 analytical sample Substances 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- JPOXNPPZZKNXOV-UHFFFAOYSA-N bromochloromethane Chemical compound ClCBr JPOXNPPZZKNXOV-UHFFFAOYSA-N 0.000 description 2
- LUEHNHVFDCZTGL-UHFFFAOYSA-N but-2-ynoic acid Chemical compound CC#CC(O)=O LUEHNHVFDCZTGL-UHFFFAOYSA-N 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 208000035269 cancer or benign tumor Diseases 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 230000017858 demethylation Effects 0.000 description 2
- 238000010520 demethylation reaction Methods 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- RCJVRSBWZCNNQT-UHFFFAOYSA-N dichloridooxygen Chemical compound ClOCl RCJVRSBWZCNNQT-UHFFFAOYSA-N 0.000 description 2
- YDVNLQGCLLPHAH-UHFFFAOYSA-N dichloromethane;hydrate Chemical compound O.ClCCl YDVNLQGCLLPHAH-UHFFFAOYSA-N 0.000 description 2
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 229940121647 egfr inhibitor Drugs 0.000 description 2
- WHQLQYRFIHPMNA-UHFFFAOYSA-N ethyl acetate;oxolane Chemical compound C1CCOC1.CCOC(C)=O WHQLQYRFIHPMNA-UHFFFAOYSA-N 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 239000011981 lindlar catalyst Substances 0.000 description 2
- NCBZRJODKRCREW-UHFFFAOYSA-N m-anisidine Chemical compound COC1=CC=CC(N)=C1 NCBZRJODKRCREW-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 229940095102 methyl benzoate Drugs 0.000 description 2
- CXHHBNMLPJOKQD-UHFFFAOYSA-M methyl carbonate Chemical compound COC([O-])=O CXHHBNMLPJOKQD-UHFFFAOYSA-M 0.000 description 2
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- HZLBHEGXFFQCCQ-UHFFFAOYSA-N n-(3-bromophenyl)-n-(3-cyano-8-methyl-6-nitroquinolin-4-yl)acetamide Chemical compound N#CC=1C=NC2=C(C)C=C([N+]([O-])=O)C=C2C=1N(C(=O)C)C1=CC=CC(Br)=C1 HZLBHEGXFFQCCQ-UHFFFAOYSA-N 0.000 description 2
- MTLDSDAPCIQSJG-UHFFFAOYSA-N n-[8-(bromomethyl)-3-cyano-6-nitroquinolin-4-yl]-n-(3-bromophenyl)acetamide Chemical compound N#CC=1C=NC2=C(CBr)C=C([N+]([O-])=O)C=C2C=1N(C(=O)C)C1=CC=CC(Br)=C1 MTLDSDAPCIQSJG-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 125000003386 piperidinyl group Chemical group 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- WDXARTMCIRVMAE-UHFFFAOYSA-N quinoline-2-carbonitrile Chemical class C1=CC=CC2=NC(C#N)=CC=C21 WDXARTMCIRVMAE-UHFFFAOYSA-N 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
- IXHNFOOSLAWRBQ-UHFFFAOYSA-N (3,4-dichlorophenyl)methanamine Chemical compound NCC1=CC=C(Cl)C(Cl)=C1 IXHNFOOSLAWRBQ-UHFFFAOYSA-N 0.000 description 1
- DIVNUTGTTIRPQA-UHFFFAOYSA-N (3,4-dimethoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C=C1OC DIVNUTGTTIRPQA-UHFFFAOYSA-N 0.000 description 1
- SUYJXERPRICYRX-UHFFFAOYSA-N (3-bromophenyl)methanamine Chemical compound NCC1=CC=CC(Br)=C1 SUYJXERPRICYRX-UHFFFAOYSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- DOTGZROJTAUYFQ-OWOJBTEDSA-N (e)-4-bromobut-2-enoic acid Chemical compound OC(=O)\C=C\CBr DOTGZROJTAUYFQ-OWOJBTEDSA-N 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- VSNHCAURESNICA-NJFSPNSNSA-N 1-oxidanylurea Chemical compound N[14C](=O)NO VSNHCAURESNICA-NJFSPNSNSA-N 0.000 description 1
- VTECVFIISKEDIZ-UHFFFAOYSA-N 2-(2-methoxyethoxy)quinoline-3-carbonitrile Chemical compound C1=CC=C2C=C(C#N)C(OCCOC)=NC2=C1 VTECVFIISKEDIZ-UHFFFAOYSA-N 0.000 description 1
- UJCZKVLHBYLLGG-UHFFFAOYSA-N 2-(dimethylaminomethylideneamino)-4,5-diethoxybenzoic acid Chemical compound CCOC1=C(C=C(C(=C1)C(=O)O)N=CN(C)C)OCC UJCZKVLHBYLLGG-UHFFFAOYSA-N 0.000 description 1
- RRQMXQWSIJERLR-UHFFFAOYSA-N 2-amino-3,6-dimethoxybenzoic acid Chemical compound COC1=CC=C(OC)C(C(O)=O)=C1N RRQMXQWSIJERLR-UHFFFAOYSA-N 0.000 description 1
- FEDLEBCVFZMHBP-UHFFFAOYSA-N 2-amino-3-methylphenol Chemical compound CC1=CC=CC(O)=C1N FEDLEBCVFZMHBP-UHFFFAOYSA-N 0.000 description 1
- GETLLXMNDLMIJO-UHFFFAOYSA-N 2-chloro-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound N#CC1=C(Cl)N=C2C=C(OC)C(OC)=CC2=C1 GETLLXMNDLMIJO-UHFFFAOYSA-N 0.000 description 1
- AVAQZFUVMGMHSC-UHFFFAOYSA-N 2-cyano-3-ethoxyprop-2-enoic acid Chemical compound CCOC=C(C#N)C(O)=O AVAQZFUVMGMHSC-UHFFFAOYSA-N 0.000 description 1
- GVBHRNIWBGTNQA-UHFFFAOYSA-N 2-methoxy-4-nitroaniline Chemical compound COC1=CC([N+]([O-])=O)=CC=C1N GVBHRNIWBGTNQA-UHFFFAOYSA-N 0.000 description 1
- XTTIQGSLJBWVIV-UHFFFAOYSA-N 2-methyl-4-nitroaniline Chemical compound CC1=CC([N+]([O-])=O)=CC=C1N XTTIQGSLJBWVIV-UHFFFAOYSA-N 0.000 description 1
- WBRPQQSADOCKCH-UHFFFAOYSA-N 2-methylsulfanylaniline Chemical compound CSC1=CC=CC=C1N WBRPQQSADOCKCH-UHFFFAOYSA-N 0.000 description 1
- QFTJOYLPELHHCO-UHFFFAOYSA-N 3,4-dibromoaniline Chemical compound NC1=CC=C(Br)C(Br)=C1 QFTJOYLPELHHCO-UHFFFAOYSA-N 0.000 description 1
- AXNUZKSSQHTNPZ-UHFFFAOYSA-N 3,4-difluoroaniline Chemical compound NC1=CC=C(F)C(F)=C1 AXNUZKSSQHTNPZ-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- GSCPDZHWVNUUFI-UHFFFAOYSA-N 3-aminobenzamide Chemical compound NC(=O)C1=CC=CC(N)=C1 GSCPDZHWVNUUFI-UHFFFAOYSA-N 0.000 description 1
- GRXMMIBZRMKADT-UHFFFAOYSA-N 3-bromo-4-methylaniline Chemical compound CC1=CC=C(N)C=C1Br GRXMMIBZRMKADT-UHFFFAOYSA-N 0.000 description 1
- MNOJRWOWILAHAV-UHFFFAOYSA-N 3-bromophenol Chemical compound OC1=CC=CC(Br)=C1 MNOJRWOWILAHAV-UHFFFAOYSA-N 0.000 description 1
- VPMAWSAODAKKSI-UHFFFAOYSA-N 3-chloroprop-2-enoyl chloride Chemical class ClC=CC(Cl)=O VPMAWSAODAKKSI-UHFFFAOYSA-N 0.000 description 1
- WEZAHYDFZNTGKE-UHFFFAOYSA-N 3-ethoxyaniline Chemical compound CCOC1=CC=CC(N)=C1 WEZAHYDFZNTGKE-UHFFFAOYSA-N 0.000 description 1
- QZVQQUVWFIZUBQ-UHFFFAOYSA-N 3-fluoroaniline Chemical compound NC1=CC=CC(F)=C1 QZVQQUVWFIZUBQ-UHFFFAOYSA-N 0.000 description 1
- FFCSRWGYGMRBGD-UHFFFAOYSA-N 3-iodoaniline Chemical compound NC1=CC=CC(I)=C1 FFCSRWGYGMRBGD-UHFFFAOYSA-N 0.000 description 1
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 description 1
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 1
- ASFAFOSQXBRFMV-LJQANCHMSA-N 3-n-(2-benzyl-1,3-dihydroxypropan-2-yl)-1-n-[(1r)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzene-1,3-dicarboxamide Chemical compound N([C@H](C)C=1C=CC(F)=CC=1)C(=O)C(C=1)=CC(N(C)S(C)(=O)=O)=CC=1C(=O)NC(CO)(CO)CC1=CC=CC=C1 ASFAFOSQXBRFMV-LJQANCHMSA-N 0.000 description 1
- XJCVRTZCHMZPBD-UHFFFAOYSA-N 3-nitroaniline Chemical compound NC1=CC=CC([N+]([O-])=O)=C1 XJCVRTZCHMZPBD-UHFFFAOYSA-N 0.000 description 1
- ZPAVWOIPGQYYKD-UHFFFAOYSA-N 4-(2-chloroethoxy)-3-methoxybenzoic acid Chemical compound COC1=CC(C(O)=O)=CC=C1OCCCl ZPAVWOIPGQYYKD-UHFFFAOYSA-N 0.000 description 1
- WPAPUDPVGSFJIK-UHFFFAOYSA-N 4-(3-acetylanilino)-5,6-bis(2-methoxyethoxy)quinoline-3-carbonitrile Chemical compound C12=C(OCCOC)C(OCCOC)=CC=C2N=CC(C#N)=C1NC1=CC=CC(C(C)=O)=C1 WPAPUDPVGSFJIK-UHFFFAOYSA-N 0.000 description 1
- RVLCDEDGRPEEFE-UHFFFAOYSA-N 4-(3-bromoanilino)quinoline-3-carboxylic acid Chemical compound OC(=O)C1=CN=C2C=CC=CC2=C1NC1=CC=CC(Br)=C1 RVLCDEDGRPEEFE-UHFFFAOYSA-N 0.000 description 1
- KUSKFYMMIJBRAS-UHFFFAOYSA-N 4-(3-bromophenyl)sulfanyl-6,7-dimethoxyquinoline-3-carbonitrile Chemical compound C=12C=C(OC)C(OC)=CC2=NC=C(C#N)C=1SC1=CC=CC(Br)=C1 KUSKFYMMIJBRAS-UHFFFAOYSA-N 0.000 description 1
- PIAZYBLGBSMNLX-UHFFFAOYSA-N 4-(3-chloropropyl)morpholine Chemical compound ClCCCN1CCOCC1 PIAZYBLGBSMNLX-UHFFFAOYSA-N 0.000 description 1
- KVYCWMHOGHOGBV-UHFFFAOYSA-N 4-(3-ethynylanilino)-5,6-bis(2-methoxyethoxy)quinoline-3-carbonitrile Chemical compound C12=C(OCCOC)C(OCCOC)=CC=C2N=CC(C#N)=C1NC1=CC=CC(C#C)=C1 KVYCWMHOGHOGBV-UHFFFAOYSA-N 0.000 description 1
- JKXQHDGUISQENF-UHFFFAOYSA-N 4-(4-chloro-2-fluoroanilino)-7-[3-(dimethylamino)propoxy]-6-methoxyquinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCN(C)C)C(OC)=CC2=C1NC1=CC=C(Cl)C=C1F JKXQHDGUISQENF-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- ZYZQSCWSPFLAFM-UHFFFAOYSA-N 4-amino-2-chlorophenol Chemical compound NC1=CC=C(O)C(Cl)=C1 ZYZQSCWSPFLAFM-UHFFFAOYSA-N 0.000 description 1
- LYYSTKXNGVLIKP-UHFFFAOYSA-N 4-bromo-n-[4-(3-bromoanilino)-3-cyanoquinolin-6-yl]but-2-enamide Chemical compound C12=CC(NC(=O)C=CCBr)=CC=C2N=CC(C#N)=C1NC1=CC=CC(Br)=C1 LYYSTKXNGVLIKP-UHFFFAOYSA-N 0.000 description 1
- WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 description 1
- FTBCOQFMQSTCQQ-UHFFFAOYSA-N 4-bromobenzenethiol Chemical compound SC1=CC=C(Br)C=C1 FTBCOQFMQSTCQQ-UHFFFAOYSA-N 0.000 description 1
- HCXMIOZRXOIQHX-UHFFFAOYSA-N 4-chloroquinoline-3-carbonitrile Chemical class C1=CC=C2C(Cl)=C(C#N)C=NC2=C1 HCXMIOZRXOIQHX-UHFFFAOYSA-N 0.000 description 1
- GPTFBBVXZVBLEN-UHFFFAOYSA-N 4-ethoxy-5-methoxy-2-nitrobenzoic acid Chemical compound CCOC1=CC([N+]([O-])=O)=C(C(O)=O)C=C1OC GPTFBBVXZVBLEN-UHFFFAOYSA-N 0.000 description 1
- NYMDPDNETOLVBS-UHFFFAOYSA-N 4-fluoro-3-methylaniline Chemical compound CC1=CC(N)=CC=C1F NYMDPDNETOLVBS-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- MDQXGHBCDCOOSM-UHFFFAOYSA-N 5-bromopyridin-3-amine Chemical compound NC1=CN=CC(Br)=C1 MDQXGHBCDCOOSM-UHFFFAOYSA-N 0.000 description 1
- OGVXUORKCBXMAD-UHFFFAOYSA-N 6,7-diethoxy-4-(4-fluoroanilino)quinoline-3-carbonitrile Chemical compound C=12C=C(OCC)C(OCC)=CC2=NC=C(C#N)C=1NC1=CC=C(F)C=C1 OGVXUORKCBXMAD-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- PZIXIFBGEDRCAM-UHFFFAOYSA-N 6-nitro-4-oxo-1h-quinoline-3-carbonitrile Chemical compound N1C=C(C#N)C(=O)C2=CC([N+](=O)[O-])=CC=C21 PZIXIFBGEDRCAM-UHFFFAOYSA-N 0.000 description 1
- ROOZTGHVHGPROJ-UHFFFAOYSA-N 7-(2-chloroethoxy)-6-methoxy-4-oxo-1h-quinoline-3-carbonitrile Chemical compound N#CC1=CN=C2C=C(OCCCl)C(OC)=CC2=C1O ROOZTGHVHGPROJ-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- 206010001167 Adenocarcinoma of colon Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 239000011547 Bouin solution Substances 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- AMANVGIZIXOICP-UHFFFAOYSA-K C(C)(=O)[O-].C(C)[C+3].C(C)(=O)[O-].C(C)(=O)[O-] Chemical compound C(C)(=O)[O-].C(C)[C+3].C(C)(=O)[O-].C(C)(=O)[O-] AMANVGIZIXOICP-UHFFFAOYSA-K 0.000 description 1
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000009465 Growth Factor Receptors Human genes 0.000 description 1
- 108010009202 Growth Factor Receptors Proteins 0.000 description 1
- 206010019754 Hepatitis cholestatic Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- VUYCBBHNGBWOJM-UHFFFAOYSA-N NCOCl Chemical compound NCOCl VUYCBBHNGBWOJM-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 1
- 206010038491 Renal papillary necrosis Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 244000290333 Vanilla fragrans Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- LKBREHQHCVRNFR-UHFFFAOYSA-K [B+3].[Br-].[Br-].[Br-] Chemical compound [B+3].[Br-].[Br-].[Br-] LKBREHQHCVRNFR-UHFFFAOYSA-K 0.000 description 1
- JXYRIQRQKAUQIY-UHFFFAOYSA-N acetic acid;oxolane Chemical compound CC(O)=O.C1CCOC1 JXYRIQRQKAUQIY-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940009456 adriamycin Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000000278 alkyl amino alkyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 1
- 229940046836 anti-estrogen Drugs 0.000 description 1
- 230000001833 anti-estrogenic effect Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 230000002927 anti-mitotic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 150000001491 aromatic compounds Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- DVECBJCOGJRVPX-UHFFFAOYSA-N butyryl chloride Chemical compound CCCC(Cl)=O DVECBJCOGJRVPX-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
- 229940127093 camptothecin Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- OQNGCCWBHLEQFN-UHFFFAOYSA-N chloroform;hexane Chemical compound ClC(Cl)Cl.CCCCCC OQNGCCWBHLEQFN-UHFFFAOYSA-N 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 229940061627 chloromethyl methyl ether Drugs 0.000 description 1
- 231100000838 cholestatic hepatitis Toxicity 0.000 description 1
- MHMUCYJKZUZMNJ-UPHRSURJSA-N cis-3-chloroacrylic acid Chemical compound OC(=O)\C=C/Cl MHMUCYJKZUZMNJ-UPHRSURJSA-N 0.000 description 1
- 238000012321 colectomy Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 201000010897 colon adenocarcinoma Diseases 0.000 description 1
- 210000004922 colonic epithelial cell Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229940111134 coxibs Drugs 0.000 description 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
- 239000003534 dna topoisomerase inhibitor Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- KTMGNAIGXYODKQ-VOTSOKGWSA-N ethyl (e)-2-cyano-3-ethoxyprop-2-enoate Chemical compound CCO\C=C(/C#N)C(=O)OCC KTMGNAIGXYODKQ-VOTSOKGWSA-N 0.000 description 1
- VPIRXVBLQOIGLC-UHFFFAOYSA-N ethyl 2-(dimethylaminomethylideneamino)-4,5-diethoxybenzoate Chemical compound CCOC(=O)C1=CC(OCC)=C(OCC)C=C1N=CN(C)C VPIRXVBLQOIGLC-UHFFFAOYSA-N 0.000 description 1
- YZOWMIHUDJVXBH-UHFFFAOYSA-N ethyl 2-amino-4,5-bis(2-methoxyethoxy)benzoate Chemical compound CCOC(=O)C1=CC(OCCOC)=C(OCCOC)C=C1N YZOWMIHUDJVXBH-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 229960005420 etoposide Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- QKGYJVXSKCDGOK-UHFFFAOYSA-N hexane;propan-2-ol Chemical compound CC(C)O.CCCCCC QKGYJVXSKCDGOK-UHFFFAOYSA-N 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 238000001239 high-resolution electron microscopy Methods 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
- UPVUQELOASQBMY-UHFFFAOYSA-N methyl 2-amino-3,4,5-trimethoxybenzoate Chemical compound COC(=O)C1=CC(OC)=C(OC)C(OC)=C1N UPVUQELOASQBMY-UHFFFAOYSA-N 0.000 description 1
- WYHBJUPMCJWBDD-UHFFFAOYSA-N methyl 2-amino-4,5-diethoxybenzoate Chemical compound CCOC1=CC(N)=C(C(=O)OC)C=C1OCC WYHBJUPMCJWBDD-UHFFFAOYSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- PQSOLLURQXDZSZ-UHFFFAOYSA-N n,n-diethylethanamine;ethyl acetate;methanol Chemical compound OC.CCOC(C)=O.CCN(CC)CC PQSOLLURQXDZSZ-UHFFFAOYSA-N 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- JQOCJKUVECLNAC-UHFFFAOYSA-N n-[4-(4-bromoanilino)-3-cyanoquinolin-6-yl]prop-2-enamide Chemical compound C1=CC(Br)=CC=C1NC1=C(C#N)C=NC2=CC=C(NC(=O)C=C)C=C12 JQOCJKUVECLNAC-UHFFFAOYSA-N 0.000 description 1
- NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000012434 nucleophilic reagent Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical group ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- AFNBMGLGYSGFEZ-UHFFFAOYSA-M potassium;ethanethioate Chemical compound [K+].CC([S-])=O AFNBMGLGYSGFEZ-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000012256 powdered iron Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 229940127293 prostanoid Drugs 0.000 description 1
- 150000003814 prostanoids Chemical class 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- PMZDQRJGMBOQBF-UHFFFAOYSA-N quinolin-4-ol Chemical compound C1=CC=C2C(O)=CC=NC2=C1 PMZDQRJGMBOQBF-UHFFFAOYSA-N 0.000 description 1
- BLTDCIWCFCUQCB-UHFFFAOYSA-N quinoline-3-carboxamide Chemical class C1=CC=CC2=CC(C(=O)N)=CN=C21 BLTDCIWCFCUQCB-UHFFFAOYSA-N 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000005932 reductive alkylation reaction Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- OUGXVMIOSSJAFK-UHFFFAOYSA-M sodium;dichloromethane;hydrogen carbonate Chemical compound [Na+].ClCCl.OC([O-])=O OUGXVMIOSSJAFK-UHFFFAOYSA-M 0.000 description 1
- 239000012439 solid excipient Substances 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 1
- 238000001149 thermolysis Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 229940044693 topoisomerase inhibitor Drugs 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000006442 vascular tone Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
- Compounds Of Unknown Constitution (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52419600A | 2000-03-13 | 2000-03-13 | |
| US524196 | 2000-03-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2248302T3 true ES2248302T3 (es) | 2006-03-16 |
Family
ID=24088181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES01918367T Expired - Lifetime ES2248302T3 (es) | 2000-03-13 | 2001-03-06 | Utilizacion de cianoquinolinas para el tratamiento o la inhibicion de polipos colonicos. |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1263503B1 (enExample) |
| JP (1) | JP2003526686A (enExample) |
| KR (2) | KR20080009294A (enExample) |
| CN (1) | CN1190197C (enExample) |
| AR (1) | AR035482A1 (enExample) |
| AT (1) | ATE308364T1 (enExample) |
| AU (2) | AU2001245452B2 (enExample) |
| BR (1) | BR0109165A (enExample) |
| CA (1) | CA2402742C (enExample) |
| DE (1) | DE60114580T2 (enExample) |
| DK (1) | DK1263503T3 (enExample) |
| EA (1) | EA200200976A1 (enExample) |
| ES (1) | ES2248302T3 (enExample) |
| HK (1) | HK1048775B (enExample) |
| HU (1) | HUP0300547A2 (enExample) |
| IL (2) | IL151249A0 (enExample) |
| MX (1) | MXPA02008836A (enExample) |
| NO (1) | NO20024356L (enExample) |
| NZ (1) | NZ521117A (enExample) |
| PL (1) | PL202873B1 (enExample) |
| TW (1) | TWI262805B (enExample) |
| WO (1) | WO2001068186A2 (enExample) |
| ZA (1) | ZA200208178B (enExample) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6576644B2 (en) | 2000-09-06 | 2003-06-10 | Bristol-Myers Squibb Co. | Quinoline inhibitors of cGMP phosphodiesterase |
| US7019012B2 (en) | 2000-12-20 | 2006-03-28 | Boehringer Ingelheim International Pharma Gmbh & Co. Kg | Quinazoline derivatives and pharmaceutical compositions containing them |
| AU2002352878B2 (en) | 2001-11-27 | 2007-11-22 | Merck Sharp & Dohme Corp. | 2-Aminoquinoline compounds |
| EP1477481B1 (en) * | 2002-01-28 | 2009-07-22 | Ube Industries, Ltd. | Process for producing quinazolin-4-one derivative |
| BR0307375A (pt) | 2002-02-05 | 2004-12-07 | Wyeth Corp | Processo para a sìntese de ácidos n-acil-2-amino-4-alcóxi-5-nitro-benzóicos |
| JP2005536462A (ja) * | 2002-04-30 | 2005-12-02 | ユン ジン ファーマスーチカル インダストリーズ カンパニー リミテッド | カスパーゼ−3阻害剤としてのキノリン誘導体、この製造方法及びこれを含む薬剤学的組成物 |
| DE10221018A1 (de) | 2002-05-11 | 2003-11-27 | Boehringer Ingelheim Pharma | Verwendung von Hemmern der EGFR-vermittelten Signaltransduktion zur Behandlung von gutartiger Prostatahyperplasie (BPH)/Prostatahypertrophie |
| CA2491191C (en) | 2002-07-15 | 2014-02-04 | Exelixis, Inc. | Receptor-type kinase modulators and methods of use |
| US7109337B2 (en) | 2002-12-20 | 2006-09-19 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| ATE458731T1 (de) | 2002-12-20 | 2010-03-15 | Pfizer Prod Inc | Pyrimidin-derivate zur behandlung von anormalem zellwachstum |
| KR101218213B1 (ko) | 2003-07-03 | 2013-01-04 | 시토비아 인크. | 카스파제의 활성인자 및 세포자멸사의 유도인자로서의4-아릴아미노-퀴나졸린 |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| CA2744997A1 (en) | 2003-09-26 | 2005-04-07 | Exelixis, Inc. | C-met modulators and method of use |
| TW200529846A (en) | 2004-02-20 | 2005-09-16 | Wyeth Corp | 3-quinolinecarbonitrile protein kinase inhibitors |
| NZ551027A (en) | 2004-04-08 | 2011-01-28 | Targegen Inc | Benzotriazine inhibitors of kinases |
| EP1758887A1 (en) | 2004-05-14 | 2007-03-07 | Pfizer Products Incorporated | Pyrimidine derivatives for the treatment of abnormal cell growth |
| CA2566332A1 (en) | 2004-05-14 | 2005-11-24 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
| JP2007537235A (ja) | 2004-05-14 | 2007-12-20 | ファイザー・プロダクツ・インク | 異常細胞増殖の治療用ピリミジン誘導体 |
| CA2592900A1 (en) | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Nitrogen containing bicyclic compounds and therapeutical use thereof |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| AU2006249596A1 (en) * | 2005-05-25 | 2006-11-30 | Wyeth | Methods of synthesizing 6-alkylaminoquinoline derivatives |
| MY167260A (en) | 2005-11-01 | 2018-08-14 | Targegen Inc | Bi-aryl meta-pyrimidine inhibitors of kinases |
| JP5688877B2 (ja) | 2005-11-11 | 2015-03-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 癌疾患の治療用キナゾリン誘導体 |
| DE102006029446A1 (de) * | 2006-06-21 | 2007-12-27 | Bayer Schering Pharma Ag | Neue 3-substituierte-Chinoline als Kinase-Inhibitoren |
| DE102006029445A1 (de) * | 2006-06-21 | 2007-12-27 | Bayer Schering Pharma Ag | Neue 3-Cyano-chinoline als Kinase-Inhibitoren |
| CA2663599A1 (en) | 2006-09-18 | 2008-03-27 | Boehringer Ingelheim International Gmbh | Method for treating cancer harboring egfr mutations |
| DE102007024470A1 (de) | 2007-05-24 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Neue Sulfoximin-substituierte Chinolin- bzw. Chinazolinderivate als Kinase-Inhibitoren |
| EP2072502A1 (de) | 2007-12-20 | 2009-06-24 | Bayer Schering Pharma Aktiengesellschaft | Sulfoximid-substituierte Chinolin- und Chinazolinderivate als Kinase-Inhibitoren |
| DK2387563T4 (da) | 2009-01-16 | 2022-07-18 | Exelixis Inc | Malatsalt af n-(4-{ [ 6, 7-bis(methyloxy)quinolin-4-yl]oxy}phenyl-n'-(4-fluorphenyl)cyclopropan-1,1-dicarboxamid, og krystallinske former deraf til behandling af cancer |
| EP2445886B1 (en) | 2009-06-25 | 2016-03-30 | Amgen, Inc | 4-aminoquinoline derivatives as pi3k inhibitors |
| JP5963672B2 (ja) | 2009-07-06 | 2016-08-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Bibw2992、その塩及びこの活性成分を含む固体医薬製剤の乾燥方法 |
| UA108618C2 (uk) | 2009-08-07 | 2015-05-25 | Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку | |
| AU2010363329A1 (en) | 2010-11-07 | 2013-05-09 | Targegen, Inc. | Compositions and methods for treating myelofibrosis |
| US9227978B2 (en) | 2013-03-15 | 2016-01-05 | Araxes Pharma Llc | Covalent inhibitors of Kras G12C |
| JO3805B1 (ar) | 2013-10-10 | 2021-01-31 | Araxes Pharma Llc | مثبطات كراس جي12سي |
| US9242965B2 (en) | 2013-12-31 | 2016-01-26 | Boehringer Ingelheim International Gmbh | Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors |
| JP6533997B2 (ja) * | 2014-12-26 | 2019-06-26 | 株式会社ヤクルト本社 | Znf143阻害活性を有する化合物およびその利用 |
| EP3280708B1 (en) * | 2015-04-10 | 2021-09-01 | Araxes Pharma LLC | Substituted quinazoline compounds and methods of use thereof |
| WO2017058728A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| US10875842B2 (en) | 2015-09-28 | 2020-12-29 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| EP3356354A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
| WO2017058902A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
| EA038635B9 (ru) | 2015-11-16 | 2021-10-26 | Араксис Фарма Ллк | 2-замещенные соединения хиназолина, содержащие замещенную гетероциклическую группу, и способы их применения |
| US11279689B2 (en) | 2017-01-26 | 2022-03-22 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer |
| US11059819B2 (en) | 2017-01-26 | 2021-07-13 | Janssen Biotech, Inc. | Fused hetero-hetero bicyclic compounds and methods of use thereof |
| EP3573964A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Benzothiophene and benzothiazole compounds and methods of use thereof |
| WO2018140514A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | 1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer |
| US11274093B2 (en) | 2017-01-26 | 2022-03-15 | Araxes Pharma Llc | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
| CN110831933A (zh) | 2017-05-25 | 2020-02-21 | 亚瑞克西斯制药公司 | 喹唑啉衍生物作为突变kras、hras或nras的调节剂 |
| EP3630745A2 (en) | 2017-05-25 | 2020-04-08 | Araxes Pharma LLC | Covalent inhibitors of kras |
| JP2020521741A (ja) | 2017-05-25 | 2020-07-27 | アラクセス ファーマ エルエルシー | がんの処置のための化合物およびその使用の方法 |
| BR112021001709A2 (pt) | 2018-08-01 | 2021-05-04 | Araxes Pharma Llc | compostos espiro heterocíclicos e métodos de uso dos mesmos para o tratamento de câncer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6002008A (en) * | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
| UA73073C2 (uk) * | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
| IL147913A0 (en) * | 1999-08-12 | 2002-08-14 | American Cyanamid Co | Nsaid and efgr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer |
-
2001
- 2001-03-06 BR BR0109165-4A patent/BR0109165A/pt not_active Application Discontinuation
- 2001-03-06 KR KR1020077027115A patent/KR20080009294A/ko not_active Ceased
- 2001-03-06 EP EP01918367A patent/EP1263503B1/en not_active Expired - Lifetime
- 2001-03-06 PL PL363072A patent/PL202873B1/pl not_active IP Right Cessation
- 2001-03-06 KR KR1020027012074A patent/KR100817423B1/ko not_active Expired - Fee Related
- 2001-03-06 IL IL15124901A patent/IL151249A0/xx active IP Right Grant
- 2001-03-06 EA EA200200976A patent/EA200200976A1/ru unknown
- 2001-03-06 ES ES01918367T patent/ES2248302T3/es not_active Expired - Lifetime
- 2001-03-06 HU HU0300547A patent/HUP0300547A2/hu unknown
- 2001-03-06 DK DK01918367T patent/DK1263503T3/da active
- 2001-03-06 WO PCT/US2001/007068 patent/WO2001068186A2/en not_active Ceased
- 2001-03-06 JP JP2001566747A patent/JP2003526686A/ja not_active Withdrawn
- 2001-03-06 NZ NZ521117A patent/NZ521117A/en unknown
- 2001-03-06 AT AT01918367T patent/ATE308364T1/de not_active IP Right Cessation
- 2001-03-06 DE DE60114580T patent/DE60114580T2/de not_active Expired - Lifetime
- 2001-03-06 AU AU2001245452A patent/AU2001245452B2/en not_active Ceased
- 2001-03-06 AU AU4545201A patent/AU4545201A/xx active Pending
- 2001-03-06 HK HK03101049.6A patent/HK1048775B/en not_active IP Right Cessation
- 2001-03-06 MX MXPA02008836A patent/MXPA02008836A/es active IP Right Grant
- 2001-03-06 CN CNB018093981A patent/CN1190197C/zh not_active Expired - Fee Related
- 2001-03-06 CA CA002402742A patent/CA2402742C/en not_active Expired - Fee Related
- 2001-03-12 TW TW090105702A patent/TWI262805B/zh active
- 2001-03-12 AR ARP010101143A patent/AR035482A1/es not_active Application Discontinuation
-
2002
- 2002-08-14 IL IL151249A patent/IL151249A/en not_active IP Right Cessation
- 2002-09-12 NO NO20024356A patent/NO20024356L/no unknown
- 2002-10-10 ZA ZA200208178A patent/ZA200208178B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2248302T3 (es) | Utilizacion de cianoquinolinas para el tratamiento o la inhibicion de polipos colonicos. | |
| US6384051B1 (en) | Method of treating or inhibiting colonic polyps | |
| ES2209124T3 (es) | "3-cianoquinolinas sustituidas". | |
| AU2001245452A1 (en) | Use of cyanoquinolines for treating or inhibiting colonic polyps | |
| US6002008A (en) | Substituted 3-cyano quinolines | |
| JP5399926B2 (ja) | 血管阻害物質とタキサンとの併用 | |
| EP2116246A1 (en) | Composition for treatment of pancreatic cancer | |
| AU2007201934B2 (en) | Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |